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Abstract 
A series of amino acid derivatives 8-10, 42 and 43 have been prepared as chromogenic 
enzyme substrates in order to detect aminopeptidase activity in clinically important Gram-
negative and Gram-positive bacteria. Enzymatic hydrolysis liberates the amino acid moiety 
and either a 4-aminophenol or a 4-dialkylaminoaniline derivative which undergoes oxidative 
coupling with 1-naphthol or a substituted 1-naphthol giving an indophenol dye. Substrates 
and 1-naphthols were incorporated into an agar-based culture medium and this allowed 
growth of intensely coloured bacterial colonies based on hydrolysis by specific enzymes. 
Red/pink coloured colonies were produced by the substrates 8-10 and blue coloured colonies 
were formed by the substrates 42 and 43. The L-alanyl aminopeptidase substrates 8 targeted 
L-alanyl aminopeptidase activity and gave coloured colonies with a range of Gram-negative 
bacteria. Substrates 9 targeted β-alanyl aminopeptidase activity and generated coloured 
colonies with selected Gram-negative species including Pseudomonas aeruginosa. Three 
substrates for L-pyroglutamyl acid aminopeptidase (10a, 10c and 43) were hydrolysed by 
enterococci and Streptococcus pyogenes to generate coloured colonies. Two yeasts were also 
included in the study, but they did not produce coloured colonies with any of the substrates 
examined. 
Keywords: aminopeptidase, bacteria detection, chromogenic substrates 
1. Introduction 
The detection and identification of pernicious microorganisms is of tremendous importance 
in the health-care sector (e.g. hospitals) and other broad areas such as food quality control 
and environmental monitoring (e.g. water contamination).1-3 One important protocol that has 
emerged for the detection and identification of microorganisms is the application of synthetic 
enzyme substrates; microbial enzymes transform either weakly coloured (or weakly 
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fluorescent) substrates into strongly coloured (or highly fluorescent) products respectively. 
The ability of a microorganism to grow on a selective culture medium alongside the 
appearance of colour (or fluorescence) resulting from the activity of a specific enzyme (e.g. 
aminopeptidase, glycosidase, phosphatase etc) has great utility for establishing the 
presumptive identification of microbial species.4 
The identification of specific types of aminopeptidase activity in microorganisms has proved 
useful in diagnostic microbiology. Of particular relevance to this paper are L-alanyl, β-alanyl 
and pyroglutamyl (PYRase) aminopeptidase activities. Thus, there has been longstanding 
interest in the detection of L-alanine aminopeptidase activity, which has enabled 
differentiation between Gram-positive and Gram-negative microorganisms.5,6 This enzyme is 
ubiquitous in Gram-negative microorganisms whereas, in contrast, it is generally absent from 
most Gram-positive microorganisms. β-Alanyl aminopeptidase has been detected in 
Pseudomonas aeruginosa, a common respiratory pathogen in cystic fibrosis patients.7 L-
Pyroglutamyl aminopeptidase activity is useful for differentiation within the family 
Enterobacteriaceae3,8 and also for detection of enterococci9 and Streptococcus pyogenes.10 
A diverse range of chromogenic aminopeptidase substrates have previously been described 
and some relevant examples (structures 1-5, AA = amino acid) are shown in Figure 1. In 
these substrates, hydrolysis of the amide bond by an appropriate aminopeptidase enzyme 
liberates the corresponding coloured amine. L-Alanyl-p-nitroanilide 1 (AA = L-alanyl) 
liberates yellow p-nitroaniline in the presence of Gram-negative microorganisms.3,11 
However, this substrate is not particularly suitable for use in agar media because of 
widespread diffusion of the p-nitroaniline. The phenoxazinone derivative 2 (AA = β-alanyl) 
has been evaluated for the detection of Pseudomonas aeruginosa in agar media and purple 
coloured colonies are produced.7 N-Methyllepidinium 312 and N-methylacridinium 45 
substrates bearing a range of pendent amino acids have been prepared and evaluated in agar 
media producing red or red-orange coloured colonies.  
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Figure 1. Chromogenic substrates for the detection of aminopeptidase activity 
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Amino acid derivatives of weakly coloured amines can also be used to detect aminopeptidase 
activity when the liberated amine is reacted with a secondary reagent in order to produce a 
coloured product.  Thus, derivatives of the acridine substrates 5 (AA = L-alanyl, β-alanyl) 
produce various shades of red-coloured colonies in agar media after the addition of acetic 
acid.13 The function of the acetic acid is to protonate the acridine-nitrogen atom of the 
liberated amine because the free base is only weakly coloured. Amino acid derivatives of α- 
and β-naphthylamine can also be used to detect aminopeptidase activity when the liberated 
amine is reacted with a diazonium salt to produce a strongly coloured dye.3,8 Amino acid 
derivatives of 4-aminophenol and 4-dialkylaminoaniline and their analogues produce 
coloured indophenol products 7 when the liberated amine undergoes oxidative coupling with 
1-naphthol in liquid media as illustrated in Scheme 1.14 This protocol has been extended to 
include glycoside derivatives of 1-naphthol in a ‘dual’ substrate procedure for microorganism 
identification; both glycosidase and aminopeptidase activity must be present in order for 
indophenol production.14  
 
In this paper we describe the synthesis and application of the 4-aminophenol derivatives 8-10 
and the 4-dialkylaminoaniline derivatives 42 and 43 as potential chromogenic substrates for 
use in agar media. Previous work on indophenol dye production has been confined to liquid 
media14 and an extension into agar media was thought to be highly desirable. 
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Scheme 1. Formation of indophenol dyes 
 
2. Synthesis of substrates 8-10 
 
We envisaged that hydrolysis of substrates of general structures 8-10 (Scheme 2, Table 1) 
would liberate the corresponding 4-aminophenol derivatives 11 which would subsequently 
undergo oxidative coupling with 1-naphthol (or a suitable analogue) producing the 
indophenol dyes 12.  
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Scheme 2. Proposed formation of indophenol dyes 12 as a result of aminopeptidase activity 
on substrates 8-10. See Table 1 for structures of X and R substituents. 
 
 
The synthesis of the required substrates 8-10 is shown in Scheme 3. Commercially available 
and inexpensive 3,4-dihydrocoumarin (13) was selected as the starting material because, after 
nitration, treatment of the nitro-compound 14 with either amines or alcohols would be 
expected to result in ring-opening of the lactone moiety enabling access to a range 
nitrophenol derivatives 15 (X = H) from a common precursor. Halogenation of compounds 
15 (X = H) could give additional structural diversity yielding halogenated products 15 (X = 
halogen). Thus, nitration of compound 13 following a literature procedure gave the nitro-
derivative 14. When compound was heated with ethanol and amines respectively, the ester 
15a (X = H) (69%) and the amides 15c-i (X = H) (59-84%) were formed. Bromination of the 
ester 15a with N-bromosuccinimide (NBS) in DMF solution gave compound 15b (X = Br) 
(83%). Reduction of nitro-derivatives 15 using lithium formate in the presence of a palladium 
catalyst afforded the corresponding amines 11 [with the exception of compound 15b which 
was reduced with tin(II) dichloride dihydrate in ethanol at reflux]. In the case of compound 
15e, the O-benzyl group was also removed under these conditions giving the product 11f. A 
mixed anhydride coupling of the amines 11 to Boc-L-alanine and Boc-β-alanine gave the 
protected amino-acid derivatives 16 and 17 respectively and subsequent removal of the Boc-
groups under acidic conditions yielded the required aminopeptidase substrates 8 and 9. The 
mixed anhydride coupling of amines 11 with L-pyroglutamic acid gave the substrates 10. 
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Scheme 3. Synthesis of aminopeptidase substrates 8-10. See Table 1 for structures of X and 
R groups. Reagents and conditions: (i) Ac2O, HNO3, AcOH, 18-20 oC; (ii) EtOH, reflux, 1h 
(15a); appropriate aniline or amine, THF, reflux, 5 h (15c-e, 15g-i); (iii) NBS, DMF, rt, 20 h 
(15a to 15b); (iv) HC(O)OLi, 10% Pd/C, THF, reflux, 2-8 h or SnCl2.2H2O, EtOH, reflux 
(15b only); (v) (a) N-methylmorpholine, iBuOC(O)Cl, Boc-L-alanine, THF, -5 oC, then add 
11, (b) rt overnight; (vi) (a) N-methylmorpholine, iBuOC(O)Cl, Boc-β-alanine, THF, -5 oC, 
then add 11, (b) rt overnight; (vii)  (a) N-methylmorpholine, iBuOC(O)Cl, L-pyroglutamic 
acid, THF/DMF 3:1, -5 oC, then add 11, (b) rt overnight; (viii) EtOAc/HCl, rt, 3 h.  
 
 X R Yield of 
15 (%) 
Yield of 
11 (%) 
Yields of 
16, 17 (%) 
Yields of 
8-10 (%) 
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H OEt
O
 
 
69 
 
66 
16a 81 
17a 79 
8a 96 
9a 96 
10a 84 
 
b 
 
Br OEt
O
 
 
83a 
 
89 
16b 76 
17b 65 
8b 98 
9b 99 
10b 45 
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8c 92 
9c 96 
10c 95 
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8d 81 
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-- 
 
-- 
 
-- 
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-- 
 
80b 
 
16f 46 
 
8f 96 
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H HN
O
Ph
CO2Me  
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91 
 
16g 89 
 
8g 97 
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H HN
O
N  
 
96 
 
98 
 
16h 68 
 
8h 93 
 
i 
 
H HN
O
N
N
 
 
65 
 
87 
 
16i 76 
 
8i 81 
 
a Formed by bromination of  15a. 
b Reduction of 15e also resulted in de-benzylation giving compound 11f. 
 
Table 1. Structures and yields of compounds synthesised as shown in Scheme 3. 
 
3. Evaluation of substrates 8-10 
 
The substrates 8-10 have been evaluated in Columbia agar medium against a range of 
clinically important microorganisms including 10 Gram-negative bacteria, 8 Gram-positive 
bacteria and 2 yeasts. 1-Naphthol was incorporated into the growth media in order to react 
with the amine 11 to produce the indophenol dyes 12 as previously noted in Scheme 2. 
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Table 2 depicts the results of the evaluation of substrates 8a-c. Plates were incubated at 37 °C 
in air for 24 h. The growth of the microorganisms was compared to control plates in which no 
substrate or 1-naphthol was present. The Gram-negative microorganisms all grew well on the 
control plates whereas the Gram-positive microorganisms and the yeasts showed only 
moderate growth. This extent of microorganism growth is generally observed when the 
substrate and 1-naphthol are both present in the plates with the exception of the yeasts which 
showed very little growth, suggesting that the substrates are inhibiting yeast growth (there is 
some growth of the yeasts in the presence of 1-naphthol and the substrates 9a-c and 10a-c 
indicating that the substrates 8a-c, rather than 1-naphthol, are inhibitory). In the presence of 
1-naphthol and substrates 8a and 8c, strongly red-coloured colonies were produced by most 
Gram-negative microorganisms as expected because these microorganisms generally exhibit 
L-alanyl aminopeptidase activity. Similarly, in the presence of 1-naphthol and the brominated 
substrate 8b strongly coloured colonies were formed by the Gram-negative microorganisms 
but these colonies were pink, rather than red. The colourations produced by substrates 8a-c 
are illustrated in Figure 2. The substrates 8d and 8f-i also produced red colonies (data not 
shown) but the colours formed were significantly less intense than those colours produced 
from substrates 8a-c.  
 
<Table 2> 
 
Table 2. Evaluation of substrates 8a-c. Substrate concentration = 300 mg L-1; 1-naphthol 
concentration = 50 mg L-1 (0.35 mM); inoculum = 100 000 colony-forming units (cfu)/spot.  
 
<Figure 2> 
 
Figure 2. Columbia agar plates depicting colour formation of substrates 8a-c with various 
microorganisms. 
 
There was some noticeable diffusion of colour around the microorganism colonies associated 
with the use of substrates 8a-c. In agar media, it is preferable to have the colour restricted to 
the colonies as this allows clear differentiation of species that demonstrate enzyme activity 
from those that do not. When the coloured product diffuses through agar, there can be some 
uncertainty about which colonies are actually showing enzyme activity if colonies of several 
species are in close proximity to each other. Such polymicrobial cultures are frequently 
recovered from pathological specimens. We have therefore investigated whether diffusion of 
colour may be restricted by replacing 1-naphthol with analogues of this compound. A series 
of 2- and 8-substituted-1-naphthols 18-24 were prepared for this purpose (Figure 3). 2-
Benzyl-1-naphthol (18) was prepared by a rhodium(III) chloride catalysed isomerisation of 
compound 25 in ethanol solution (90%). Treatment of commercially available phenyl 1-
naphthol-2-carboxylate with 4-(aminomethyl)pyridine gave compound 19 (75%) and the 
reaction of phenylmagnesium bromide with 1,8-naphthosultone 26 afforded the known 
sulphone derivative 20. The 1-naphthol derivatives 21-24 were all prepared by heating the 
lactone 27 with either ethanol [giving compound 21 (63%)] or an appropriate amine affording 
amides 22-24 (45-95%).  
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Figure 3. 1-Naphthol analogues 18-24 and their precursors 25-27. 
 
The 1-naphthol analogues 18-24 were all evaluated with substrate 8b and the results were 
compared to 1-naphthol (see Figure 4 for four illustrative plates). The range of 
microorganisms that produced coloured colonies with these additional naphthols was broadly 
similar to the range that produced coloured colonies with 1-naphthol. However, some 
diffusion of colour from the colonies into the surrounding agar was still apparent with these 
additional naphthol derivatives. Naphthols 20, 21, 23 and 24 produced red coloured colonies 
and the naphthol 18 gave orange coloured colonies. In contrast, the amides 19 and 22 bearing 
the basic pyridine and primary amine groups respectively, both afforded blue/purple coloured 
colonies.  
 
<Figure 4> 
 
Figure 4. Colours produced from substrate 8b (concentration 300 mg L-1) and 
microorganisms in the presence of four 1-naphthol analogues (concentration 0.35 mM). Top 
left, compound 23; top right, compound 24; bottom left, compound 22; bottom right, 
compound 18. See Figure 2 for the arrangement of the microorganisms on the plates. 
 
In view of the most intense coloured colonies being produced with the L-alanyl 
aminopeptidase substrates 8a-c, the preparation of β-alanyl aminopeptidase and PYRase 
substrates were therefore based on these three core structures. Table 3 shows the results 
obtained for the β-alanyl substrates 9a-c. Gram-negative microorganisms grew well on the 
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media and the Gram-positive microorganisms and the yeasts generally exhibited moderate 
growth. Coloured colonies were not formed by any of the Gram-positive microorganisms or 
by the yeasts. Of the Gram-negative microorganisms, only Pseudomonas aeruginosa 
produced colonies with significant colouration; the colour produced with substrate 9b was 
particularly strong. There were some weakly coloured colonies produced by Serratia 
marcescens with substrates 9a and 9b. As noted in the introduction, Pseudomonas 
aeruginosa exhibits β-alanyl aminopeptidase activity and this microorganism is being 
effectively detected by substrate 9b although some diffusion of colour into the surrounding 
media was still apparent. Other than P. aeruginosa, a limited number of species have been 
reported to produce β-alanyl aminopeptidase including some strains of Burkholderia cepacia 
complex and Serratia marcescens.5 The specificity of substrate 9b was therefore entirely 
consistent with previous reports. 
 
 
<Table 3> 
 
Table 3. Evaluation of substrates 9a-c. Substrate concentration = 300 mg L-1; 1-naphthol 
concentration = 50 mg L-1 (0.35 mM); inoculum = 100 000 cfu/spot.  
 
<Table 4> 
Table 4. Evaluation of substrates 10a-c. Substrate concentration = 300 mg L-1; 1-naphthol 
concentration = 50 mg L-1 (0.35 mM); inoculum = 100 000 cfu/spot.  
 
Substrates 10a and 10c were hydrolysed by enterococci and Streptococcus pyogenes to 
generate a pink coloration. The principal value of PYRase as a diagnostic marker is in the 
differentiation of S. pyogenes and enterococci from most other Gram-positive cocci.9, 15 A 
range of selective culture media have been designed for detection of enterococci and these 
have traditionally relied upon chromogenic substrates for detection of β -glucosidase activity, 
which is a less specific marker than PYRase. One reason for this is likely to be the lack of 
available chromogenic substrates for PYRase that are suitable for use in culture media. 
Streptococcus pyogenes is a significant human pathogen and the principal cause of bacterial 
pharyngitis and such substrates are potentially very useful for differentiation of this species 
from commensal bacteria.   
 
4. Synthesis and evaluation of additional L-alanyl substrates 
 
In order to try and restrict the diffusion of the chromophore within the media, the higher 
molecular mass bis-L-alanyl substrates 31 have been prepared from compound 14 (Scheme 
4). Thus, reaction of compound 14 with either para-phenylene diamine hydrochloride under 
basic conditions or with ethylene diamine gave the nitro-compounds 28. Reduction of 
compounds 28 afforded the corresponding amines 29 from which the Boc-protected amino 
acid derivatives 30 were synthesised using a mixed anhydride coupling procedure. Treatment 
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of compounds 30 with hydrogen chloride resulted in removal of the Boc-groups giving the 
required substrates 31. 
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Scheme 4. Synthesis of substrates 31. Reagents and conditions: (i) 1,4-H2NC6H4NH2.HCl, 
NaHCO3, THF, reflux (28a); H2NCH2CH2NH2, THF, reflux (28b); (ii) HC(O)OLi, 10% 
Pd/C, THF/DMF 2:1, 80 oC; (iii) (a) N-methylmorpholine, iBuOC(O)Cl, Boc-L-alanine, 
THF/DMF 2:1 (29a) or THF (29b), -5 oC, then add 29, (b) rt overnight; (iv) EtOAc/HCl, rt, 3 
h. 
 
Additionally, the substrate 37 which bears both an L-alanyl moiety and a naphthol fragment 
within the same molecule was prepared (Scheme 5). It was anticipated that this substrate 
would undergo intermolecular oxidative coupling after hydrolysis of the L-alanyl group. 
Thus, reaction of the nitrocoumarin 14 with Boc-ethylenediamine gave the Boc-protected 
amine 32 from which the Boc-group was removed by treatment with hydrogen chloride in 
ethyl acetate affording compound 33. Compound 33 was reacted under basic conditions with 
phenyl 1-hydroxy-2-naphthoate giving the nitro-derivative 34 which was then reduced 
yielding the amine 35. A mixed anhydride coupling of this amine with Boc-L-alanine 
furnished compound 36 which, on treatment with hydrogen chloride in ethyl acetate afforded 
the required substrate 37. 
 
10 
 
O O
O2N
OH
O2N
O
H
N
NHR
OH
R
O
H
N
N
H
O OH
32 R = Boc
33 R = H. HCl
OH
N
H
O
H
N
N
H
O OHO
BocHN
Me
OH
N
H
O
H
N
N
H
O OHO
HCl.H2N
Me
(i) (iii)
(ii)
(v)
(vi)
14
34 R = NO2
35 R = NH2
(iv) 71%
36 37
76%
99%
96% 72%
30%
 
  
Scheme 5. Synthesis of substrate 37. Reagents and conditions: (i) BocNHCH2CH2NH2, THF, 
reflux; (ii) HCl/EtOAc, rt; (iii) phenyl 1-hydroxy-2-naphthoate, NaHCO3, DMF/THF, reflux; 
(iv) HC(O)OLi, 10% Pd/C, THF/DMF 2:1, 80 oC; (v) (a) N-methylmorpholine, iBuOC(O)Cl, 
Boc-L-alanine, THF/DMF 2:1, -5 oC, then add 35, (b) rt overnight; (vi) HCl/EtOAc, rt, 3h. 
 
Disappointingly, substrate 31a gave only very weakly, pink coloured colonies with some 
Gram-negative microorganisms (data not shown) in the presence of 1-naphthol. Neither 
substrate 31b (in the presence of 1-naphthol) nor substrate 37 (with no added 1-naphthol) 
produced any coloured colonies. This may be a consequence of the substrates being unable to 
penetrate into the bacterial cell. In support of this hypothesis, substrates 31b and 37 were 
added to a cell-free E. coli extract (containing 1-naphthol in the case of substrate 31b) and 
this resulted in the formation of  pale orange solutions with both substrates, indicative of 
oxidative coupling and hence aminopeptidase activity (Figure 5). We have therefore 
speculated that these larger substrates may not pass efficiently through the bacterial cell 
membrane(s). When sodium periodate was added to the mixture (in order to assist the 
oxidative coupling to 1-naphthol), a slightly more intense colouration was produced. Also 
shown in Figure 5 is substrate 8b which was selected as a comparator because this compound 
is known to give coloured colonies in agar media and hence was expected to produce a 
coloured solution with the cell-free extract in the absence of any additional oxidising agent. 
 
<Figure 5> 
 
Figure 5. Performance of substrates 31b (top left), 37 (top right) and 8b (bottom) in the 
presence of an E. coli cell free extract (CFE). Left tube: buffer (0.1 M Tris pH 7.4) + 
substrate (150 mg L-1); middle tube: buffer + E coli CFE + substrate (150 mg L-1); right tube: 
buffer + E. coli CFE + substrate (150 mg L-1) + sodium periodate (150 mg L-1). 1-Naphthol 
(50 mg L-1) was added to all three tubes associated with substrates 31b and 8b. 
 
5. Synthesis and evaluation of substrates 42 and 43. 
 
In view of the successful colour formation from substrates 8a and 10, we turned our attention 
to the preparation and evaluation of the corresponding para-phenylenediamine-derived 
substrates 42 and 43 (Scheme 6). 4-Fluoronitrobenzene was reacted with γ-aminobutyric acid 
under basic conditions yielding the carboxylic acid derivative 38 (62%) which was then 
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coupled to 2-phenylethylamine giving the amide 39. This amide-containing chain was chosen 
in order to restrict diffusion in agar media of the dye that would be formed from the oxidative 
coupling of the hydrolysed substrates (i.e. amine 40) and a 1-naphthol derivative. Reduction 
of compound 39 gave the amine 40 which was coupled with either Boc-L-alanine giving 
compound 41 or L-pyroglutamic acid affording the substrate 43. Removal of the Boc-group 
from compound 41 yielded the substrate 42. 
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Scheme 6. Synthesis of substrates 42 and 43. Reagents and conditions: (i) N-
methylmorpholine, iBuOC(O)Cl, THF, -5 oC, then add PhCH2CH2NH2; (ii) SnCl2.2H2O, 
EtOH, reflux; (iii), (a) N-methylmorpholine, iBuOC(O)Cl, Boc-L-alanine, THF, -15 oC, then 
add 40, (b) rt overnight (iv) TFA, CH2Cl2, rt; (v) (a) N-methylmorpholine, iBuOC(O)Cl, L-
pyroglutamic acid, THF/DMF 10:1, -15 oC, then add 40, (b) rt overnight. 
 
The substrates 42 and 43 were evaluated in a similar manner to that described to that 
described above for substrates 8-10 (Table 5). In the presence of the naphthol derivative 20, 
the L-alanyl substrate 42 produced intensely blue coloured colonies with the Gram-negative 
microorganisms as expected (Figure 6). However, blue coloured colonies were also produced 
with a number of the Gram-positive microorganisms which could limit the application of this 
substrate for the differentiation of Gram-negative and Gram-positive microorganisms. As 
noted earlier, PYRase substrates are useful for the identification of S. pyogenes. Substrate 43 
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produced intensely blue coloured colonies with this microorganism in the presence of 1-
naphthol. 
<Table 5> 
Table 5. Evaluation of substrates 42 and 43. Substrate concentration = 300 mg L-1; naphthol 
20 concentration = 80 mg L-1or 1-naphthol = 50 mg L-1; inoculum = 100 000 cfu/spot. 
<Figure 6> 
Figure 6. Evaluation of substrate 42 in the presence of naphthol derivative 20 against various 
microorganisms. Top plate: 20 microorganisms arranged as indicated in Figure 2; bottom left 
plate: Pseudomonas aeruginosa; bottom right plate: E. coli. 
 
 
6. Conclusions 
 
Compounds 8-10 are effective chromogenic substrates producing red/pink coloured colonies 
with selected Gram-negative and Gram-positive bacteria in agar media containing 1-
naphthol. There is some diffusion of colour from the bacterial colonies which could limit 
their applications in agar media. The production of the coloured bacterial colonies is linked to 
the type of aminopeptidase activity associated with specific bacteria. Analogues of 1-
naphthol that possess pendent basic functionalities can give rise to blue, rather than red 
coloured colonies. Higher molecular mass L-alanyl substrates are not effective chromogenic 
substrates for use in agar media but some colour development is apparent with a cell free E. 
coli extract in liquid media. Substrate 43 was an effective PYRase substrate producing blue 
coloured colonies. Of the two yeasts studied, neither produced any significant colour with 
any of the substrates evaluated, which is expected as neither is known to demonstrate the 
targeted enzymatic activities. 
 
 
7. Experimental  
 
7.1. Synthetic work 
1H-NMR spectra (270 or 400 MHz) and 13C-NMR spectra (68 or 101 MHz) were recorded on 
a Jeol EX270 or Jeol ECS400 instrument.  Low resolution mass spectra (LRMS) were 
recorded via direct injection of dilute methanolic solutions (containing 0.1% formic acid) into 
a Thermo Finnigan LCQ Advantage MS detector using electrospray ionisation (ESI). High 
resolution mass spectrometry (HRMS) was performed by the EPSRC mass spectrometry 
service.  Infrared spectra were obtained via a diamond anvil sample cell using a Perkin Elmer 
1000 spectrometer. Melting points are reported uncorrected as determined on a Stuart SMP 1 
melting point apparatus. Thin layer chromatography was performed on Merck plastic foil 
plates pre-coated with silica gel 60 F254. Merck silica gel 60 was used for column 
chromatography.   
7.1.1. 6-Nitro-3,4-dihydrocoumarin 14. To a stirred solution of 3,4-dihydrocoumarin 13 
(18.00 g, 121.5 mmol) in acetic anhydride (90 mL) was added, dropwise, a mixture of 
13 
 
concentrated nitric acid (15 mL) and glacial acetic acid (30 mL) keeping the temperature 
between 18-20 °C . The mixture was stirred (1 h) and then poured into a mixture of ice and 
water (500 mL). The resulting precipitate was collected, washed well with water and dried in 
a desiccator under vacuum. The crude product was  recrystallized from ethanol (100 mL) 
giving compound 14 (17.00 g, 73%) as yellow crystals, m.p. 128-130 °C, lit. m.p. 130 °C.16 
LRMS (ES) for C9H7NO4. Calculated mass of molecular ion: 216.16 [M+Na]+. Measured 
mass: 216.15; IR νmax cm-1 1778, 1514, 1327, 1246, 1089; 1H-NMR (400 MHz; d6-DMSO) δH 
8.28 (1H, d, J = 2.8 Hz, Ar-H), 8.15 (1H, dd, J = 8.7 and 2.8 Hz, Ar-H), 7.30 (1H, d, J = 8.7 
Hz, Ar-H), 3.15 (2H, t, J = 7.3 Hz, CH2), 2.88 (2H, t, J = 7.3 Hz, CH2); 13C-NMR (101 MHz; 
d6-DMSO) δC 167.7 (C=O), 156.9 (Ar-C), 143.9 (Ar-C), 125.7 (Ar-C), 124.6 (Ar-C), 124.3 
(Ar-C), 118.0 (Ar-C), 28.2 (CH2), 23.0 (CH2).  
7.1.2 Synthesis of Nitrophenols 15, 28, 32 and 34 
7.1.2.1. Ethyl 3-(2-Hydroxy-5-nitrophenyl)propanoate 15a. To a stirred solution of 
compound 13 (18.00 g, 121.5 mmol) in acetic anhydride (90 mL) was added, dropwise, a 
mixture of concentrated nitric acid (15 mL) and glacial acetic acid (30 mL), keeping the 
temperature between 18-20 °C . The mixture was stirred (1 h) and then poured into a mixture 
of ice and water (500 mL). The resulting precipitate was collected, and dried in a desiccator 
under vacuum. The dried product was then heated in ethanol (200 mL) at reflux for 1 h, 
allowed to cool to rt and then evaporated. Half of the crude product was kept to be used for 
synthesis of compound 15b, the other half was washed with ice cold ethanol (30 mL) and 
dried to afford compound 15a (10.02 g, 69%), m.p. 86-88 °C, lit. m.p. 89.5-90 °C.17 LRMS 
(ES) for C11H13NO5. Calculated mass of molecular ion 262.22 [M+Na]+. Measured mass: 
262.21; IR νmax cm-1 3320-3280, 1692 1493, 1332, 1231, 1081; 1H-NMR (400 MHz; d6-
DMSO) δH 11.18 (1H, s, broad, OH), 8.04-7.99 (2H, m, Ar-H), 6.97 (1H, d, J = 8.24 Hz, Ar-
H), 4.05 (2H, q, J = 7.0 Hz, CH2CH3), 2.86 (2H, t, J = 7.3 Hz, CH2CH2CO), 2.62 (2H, t, J = 
7.3 Hz, CH2CO), 1.16 (3H, t, J = 7.1 Hz, CH3); 13C-NMR (101 MHz; d6-DMSO) δC 172.7 
(C=O), 162.5 (Ar-C), 139.8 (Ar-C), 128.3 (Ar-C), 126.2 (Ar-C), 124.6 (Ar-C), 115.5 (Ar-C), 
60.4 (CH2CH3), 33.2 (CH2), 25.6 (CH2), 14.6 (CH3). 
7.1.2.2. Ethyl 3-(3-Bromo-2-hydroxy-5-nitrophenyl)propanoate 15b. Compound 15a 
(1.00 g, 4.18 mmol) was dissolved in DMF (30 mL) and N-bromosuccinimide (0.82 g, 4.61 
mmol) was added. The mixture was stirred for 20 h at rt after which time the solvent was 
evaporated. Water (20 mL) was added to the residue and the precipitate was collected and 
washed well with cold water (200 mL). The resulting orange granules were dried in a 
desiccator under vacuum giving compound 15b (1.10 g, 83%), m.p. 99-100 °C. HRMS  
(APCI) for C11H12BrNO5. Calculated mass of molecular ion 317.9972 [M+H]+. Measured 
mass: 317.9973; IR νmax cm-1 3500-2800, 1694, 1510, 1320, 1223, 1156, 702; 1H-NMR (400 
MHz; d6-DMSO) δH 11.01 (1H, s, broad, OH), 8.27 (1H, d, J = 2.8 Hz, Ar-H), 8.06 (1H, d, J 
= 2.8 Hz, Ar-H), 4.07 (2H, q, J = 7.2 Hz, CH2O), 2.97 (2H, t, J = 7.3 Hz, CH2CH2CO ), 2.64 
(2H, t, J = 7.3 Hz, CH2CO), 1.17 (3H, t, J = 7.1 Hz, CH3); 13C-NMR (101 MHz; d6-DMSO) 
δC 172.5 (C=O), 158.7 (Ar-C), 140.3 (Ar-C), 130.4 (Ar-C), 127.2 (Ar-C), 125.4 (Ar-C), 
111.0 (Ar-C), 60.5 (CH2CH3), 33.3 (CH2), 26.3 (CH2), 14.6 (CH3). 
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7.1.2.3. N-(2H-1,3-Benzodioxol-5-yl)-3-(2-hydroxy-5-nitrophenyl)propanamide 15c. To a 
stirred solution of compound 14 (1.00 g, 5.18 mmol) in THF (30 mL) was added 3,4-
(methylenedioxy)aniline (0.71 g, 5.18 mmol). The mixture was stirred at reflux for 5 h. The 
solution was allowed to cool and kept overnight. The resulting crystals were collected and 
dried affording compound 15c (1.43 g, 84%) as shiny yellow crystals, m.p. 233-236 °C. 
HRMS (NSI) for C16H14N2O6. Calculated mass of molecular ion 331.0925 [M+H]+. 
Measured mass: 331.0924; IR νmax cm-1 3331, 3200, 1633, 1562, 1478, 1332, 1282, 1241, 
1192, 1036, 786; 1H-NMR (270 MHz; d6-DMSO) δH 11.14 (1H, broad, s, OH), 9.85 (1H, s, 
NH), 8.07-7.98 (2H, m, Ar-H), 7.29 (1H, d, J = 2.0 Hz, Ar-H), 7.00-6.81 (3H, m, Ar-H), 5.97 
(2H, s, CH2O), 2.90 (2H, t, J = 7.6 Hz, CH2CH2CO), 2.60 (2H, t, J = 7.6 Hz, CH2CO); 13C-
NMR (68 MHz; d6-DMSO) δC 170.5 (C=O), 162.5 (Ar-C), 147.5 (Ar-C), 143.3 (Ar-C), 139.9 
(Ar-C), 134.2 (Ar-C), 129.2 (Ar-C), 126.1 (Ar-C), 124.5 (Ar-C), 115.6 (Ar-C), 112.4 (Ar-C), 
108.6 (Ar-C), 101.9 (Ar-C), 101.5 (CH2O), 35.9 (CH2), 25.8 (CH2).  
7.1.2.4. N-(3,4-Dimethoxyphenyl)-3-(2-hydroxy-5-nitrophenyl)propanamide 15d. To a 
stirred solution of compound 14 (1.00 g, 5.18 mmol) in THF (20 mL) was added 3,4-
dimethoxyaniline (0.79 g, 5.18 mmol). The resulting mixture was stirred at reflux for 2 h, 
filtered and evaporated. The residue was recrystallized from ethanol (20 mL) affording 
compound 15d (0.90 g, 50%) as light brown crystals, m.p. 188-190 °C.  HRMS (NSI) for 
C17H18N2O6. Calculated mass of molecular ion 347.1238 [M+H]+. Measured mass: 347.1242; 
IR νmax cm-1 3364, 3300-2700, 1635, 1509, 1327, 1290, 1230, 1023; 1H-NMR (400 MHz; d6-
DMSO) δH 11.16 (1H, s, broad, OH), 9.82 (1H, s, NH), 8.08 (1H, d, J = 2.8 Hz, Ar-H), 8.02 
(1H, dd, J = 9.2 and 3.3 Hz, Ar-H), 7.29 (1H, d, J = 2.3 Hz, Ar-H), 7.08 (1H, dd, J = 8.7 and 
2.3 Hz, Ar-H), 6.99 (1H, d, J = 9.2 Hz, Ar-H), 6.89 (1H, d, J = 8.7 Hz, Ar-H), 3.20 (2 x 3H, 
d, J = 4.1 Hz, 2 x CH3), 2.93 (2H, t, J = 7.6 Hz, CH2CH2CO), 2.62 (2H, t, J = 7.6 Hz, 
CH2CO); 13C-NMR (101 MHz; d6-DMSO) δC 170.3 (C=O), 162.5 (Ar-4°C), 149.0 (Ar-4°C), 
145.2 (Ar-C),  139.9 (Ar-C), 133.3 (Ar-C), 129.1 (Ar-C), 126.1 (Ar-C), 124.5 (Ar-C), 115.5 
(Ar-C), 112.5 (Ar-C), 111.6 (Ar-C), 104.9 (Ar-C), 56.2 (CH3), 55.8 (CH3), 35.9 (CH2), 25.9 
(CH2).  
7.1.2.5. N-(4-Benzyloxyphenyl)-3-(2-hydroxy-5-nitrophenyl)propanamide 15e.  To a 
stirred solution of compound 14 (1.00 g, 5.18 mmol) in THF (20 mL) was added NaHCO3 
(0.66 g, 7.77 mmol) and 4-benzyloxyaniline hydrochloride (1.22 g, 5.18 mmol). The resulting 
mixture was stirred at reflux for 12 h and then was evaporated. The residue was recrystallized 
from ethanol (50 mL) affording compound 15e (1.20 g, 59%) as an orange powder, m.p. 239-
241 °C. HRMS (NSI) for C22H20N2O5. Calculated mass of molecular ion 393.1445 [M+H]+. 
Measured mass: 393.1450; IR νmax cm-1 3364, 1612, 1539, 1326, 1286, 1241, 827; 1H-NMR 
(270 MHz; d6-DMSO) δH 11.14 (1H, broad, s, OH), 9.78 (1H, s, NH), 8.04 (1H, d, J = 3.0 
Hz, Ar-H), 7.98 (1H, dd, J = 8.9 and 3.0 Hz, Ar-H), 7.49-7.28 (7H, m, Ar-H), 6.94 (3H, t, J = 
8.5 Hz, Ar-H), 5.03 (2H, s, CH2O), 2.88 (2H, t, J = 7.6 Hz, CH2CH2CO), 2.58 (2H, t, J = 7.6 
Hz, CH2CO); 13C-NMR (68 MHz; d6-DMSO) δC 170.3 (C=O), 162.5 (Ar-C), 154.7 (Ar-C), 
139.9 (Ar-C), 137.8 (Ar-C), 133.1 (Ar-C), 129.2 (Ar-C), 129.0 (2 x Ar-C), 128.3 (Ar-C), 
128.2 (2 x Ar-C), 126.1 (Ar-C), 124.5 (Ar-C), 121.2 (2 x Ar-C), 115.6 (Ar-C), 115.4 (2 x Ar-
C), 69.9 (CH2O), 35.9 (CH2), 25.8 (CH2).  
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7.1.2.6. (S)-Methyl 2-[3-(2-Hydroxy-5-nitrophenyl)propanamido]-2-phenyl-2-
carboxylate 15g.  To a stirred solution of compound 14 (0.50 g, 2.59 mmol) in THF (20 mL) 
was added NaHCO3 (0.23 g, 2.74 mmol) and (S)-(+)-2-phenylglycine methyl ester 
hydrochloride (0.52 g, 2.59 mmol). The resulting mixture was stirred at reflux for 3 h, filtered 
and was evaporated. The residue was recrystallized from ethanol/water affording compound 
15g (0.80 g, 86%) as a light yellow powder, m.p. 147-149 °C.  HRMS (NSI) for C18H18N2O6. 
Calculated mass of molecular ion 359.1238 [M+H]+. Measured mass: 359.1242; IR νmax cm-1 
3360, 3330-2750, 1729, 1622, 1538, 1336, 1287; 1H-NMR (400 MHz; d6-DMSO) δH 8.79 
(1H, d, J = 7.3 Hz, NH), 8.03-7.97 (2H, m, Ar-H), 7.40-7.30 (5H, m, Ar-H), 6.95 (1H, d, J = 
8.7 Hz, Ar-H), 5.42 (1H, d, J = 6.9 Hz, CHNH), 3.61 (3H, s, CH3), 2.83 (2H, t, J = 7.8 Hz, 
CH2CH2CO), 2.55-2.50 (2H, m, CH2CO; 13C-NMR (101 MHz; d6-DMSO) δC 172.0 (C=O), 
171.6 (C=O), 162.6 (Ar-C), 139.8 (Ar-C), 136.8 (Ar-C), 129.2 (2 x Ar-C), 129.1 (Ar-C), 
128.7 (2 x Ar-C), 128.2 (Ar-C), 126.1 (Ar-C), 124.4 (Ar-C), 115.5 (Ar-C), 56.7 (CHNH), 
52.7 (CH3), 34.4 (CH2), 25.7 (CH2). 
7.1.2.7. 3-(2-Hydroxy-5-nitrophenyl)-N-(4-pyridylmethyl)propanamide 15h. To a stirred 
solution of compound 14 (1.00 g, 5.18 mmol) in THF (30 mL) was added  4-
(aminomethyl)pyridine (0.56 g, 5.18 mmol). The resulting mixture was stirred at reflux for 2 
h and then evaporated. The residue was recrystallized from ethanol (30 mL) affording 
compound 15h (1.49 g, 96%) as light orange crystals, m.p. 230-233 °C. HRMS (NSI) for 
C15H15N3O4. Calculated mass of molecular ion 302.1135 [M+H]+. Measured mass: 302.1139; 
IR νmax cm-1 3318, 3250-2700, 1650, 1587, 1538, 1326, 1287, 1014; 1H -NMR (270 MHz; d6-
DMSO) δH 11.15 (1H, broad, s, OH), 8.52 (1H, t, J = 5.9 Hz, NH), 8.42 (2H, d, J = 5.9 Hz, 
Ar-H), 8.05 (2H, m, Ar-H), 7.12 (2H, d, J = 5.9 Hz, Ar-H), 6.99 (1H, d, J = 9.2 Hz, Ar-H), 
4.29 (2H, d, J = 5.9 Hz, CH2NH), 2.89 (2H, t, J = 7.4 Hz, CH2CH2CO), 2.55 (2H, t, J = 7.4 
Hz, CH2CO); 13C-NMR (68 MHz; d6-DMSO) δC 172.2 (C=O), 162.6 (Ar-C), 149.9 (2 x Ar-
C), 149.1 (Ar-C), 139.9 (Ar-C), 129.1 (Ar-C), 126.2 (Ar-C), 124.5 (Ar-C), 122.5 (2 x Ar-C), 
115.6 (Ar-C), 41.6 (CH2NH), 34.8 (CH2), 25.9 (CH2). 
7.1.2.8. 3-(2-Hydroxy-5-nitrophenyl)-N-(3-imidazol-1-ylpropyl)propanamide 15i.  To a 
stirred solution of compound 14 (1.00 g, 5.18 mmol) in THF (30 mL) was added 1-(3-
aminopropyl)imidazole (0.65 g, 5.18 mmol). The resulting mixture was stirred at reflux for 5 
h and then was evaporated. The residue was recrystallized from methanol (15 mL) affording 
compound 15i (1.07 g, 65%) as a yellow powder, m.p. 157-158 °C.  HRMS (NSI) for 
C15H18N4O4. Calculated mass of molecular ion 319.1401 [M+H]+. Measured mass: 319.1404; 
IR νmax cm-1 3313, 3150-2400, 1640, 1492, 1330, 1288, 1228, 1082, 740; 1H-NMR (400 
MHz; d6-DMSO) δH 8.04-7.94 (3H, m, 2 x Ar-H, NH), 7.62 (1H, s, Ar-H), 7.15 (1H, s, Ar-
H), 6.95 (1H, d, J = 8.7 Hz, Ar-H), 6.90 (1H, s, Ar-H), 3.90 (2H, t, J = 6.9 Hz, 
CH2CH2CH2NH), 3.00 (2H, q, J = 6.4 Hz, CH2CH2CH2NH), 2.84 (2H, t, J = 7.3 Hz, CH2), 
2.43 (2H, t, J = 7.3 Hz, CH2), 1.79 (2H, p, J = 6.9 Hz, CH2CH2CH2NH); 13C-NMR (101 
MHz; d6-DMSO) δC 171.9 (C=O), 162.9 (Ar-C), 139.6 (Ar-C), 137.8 (Ar-C), 129.2 (Ar-C), 
128.7 (Ar-C), 126.0 (Ar-C), 124.4 (Ar-C), 119.8 (Ar-C), 115.4 (Ar-C), 44.0 (CH2), 36.1 
(CH2), 34.9 (CH2), 31.3 (CH2), 25.9 (CH2).  
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7.1.2.9. 3-(2-Hydroxy-5-nitrophenyl)-N-[4-[3-(2-hydroxy-5-
nitrophenyl)propanamido]phenyl]propanamide 28a. To a stirred solution compound 14 
(1.00 g, 5.18 mmol) in THF (40 mL), NaHCO3 (0.44 g, 5.18 mmol) and para-
phenylenediamine dihydrochloride (0.47 g, 2.59 mmol) were added. The mixture was stirred 
at reflux for 48 hours. The mixture was allowed to cool, filtered and the solid was washed 
well with water and then dried in a desiccator under vacuum giving compound 28a (1.10 g, 
85%) as a white powder, m.p. > 260 °C.  LRMS (ES) for C24H22N4O8. Calculated mass of 
molecular ion 495.14 [M+H]+. Measured mass: 495.32; IR νmax cm-1 3368, 3134, 1634, 1562, 
1331,1276, 1084; 1H-NMR (400 MHz; d6-DMSO) δH 11.46 (2H, broad, s, 2 x OH), 10.05 
(2H, s, 2 x NH), 8.06 (2H, d, J = 3.2 Hz, Ar-H), 8.00 (2H, dd, J = 9.2 and 2.8 Hz, Ar-H), 7.51 
(4H, s, Ar-H), 7.12 (2H, d, J = 8.7 Hz, Ar-H), 2.90 (4H, t, J = 7.6 Hz, 2 x CH2CH2CO), 2.63 
(4H, t, J = 7.6 Hz, 2 x CH2CO); 13C-NMR (101 MHz; d6-DMSO) δC 170.5 (2 x C=O), 162.7 
(2 x Ar-C), 139.7 (2 x Ar-C), 135.0 (2 x Ar-C), 129.1 (2 x Ar-C), 126.1 (2 x Ar-C), 124.5 (2 
x Ar-C), 120.0 (4 x Ar-C), 115.5 (2 x Ar-C), 35.9 (2 x CH2), 25.8 (2 x CH2).  
  
7.1.2.10. 3-(2-Hydroxy-5-nitrophenyl)-N-[2-[3-(2-hydroxy-5-
nitrophenyl)propanamido]ethyl]propanamide 28b. To a stirred solution of compound 14 
(1.50 g, 7.77 mmol) in THF (50 mL), ethylenediamine (0.24 g, 3.99 mmol) was added and 
the resulting mixture was stirred at reflux for 5 h. The volume was then reduced and the 
solution was left to cool overnight. The resulting solid was collected and dried affording 
compound 28b (1.70 g, 98%) as a yellow powder, m.p. > 260 °C.  HRMS (NSI) for 
C20H22N4O8. Calculated mass of molecular ion 445.1365 [M-H]-. Measured mass: 445.1360; 
IR νmax cm-1 3370, 3300-2500, 1622, 1583, 1540, 1326, 1286, 1240, 751; 1H-NMR (400 
MHz; d6-DMSO) δH 7.95-7.91 (4H, m, Ar-H), 7.89-7.85 (2H, m, 2 x NH), 6.87 (2H, d, J = 
9.2 Hz, Ar-H), 3.30-2.97 (4H, m, 2 x CH2NH), 2.76 (4H, t, J = 7.6 Hz, 2 x CH2CH2CO), 2.32 
(4H, t, J = 7.6 Hz, 2 x CH2CO); 13C-NMR (101 MHz; d6-DMSO) δC 172.0 (2 x C=O), 163.4 
(2 x Ar-C), 139.3 (2 x Ar-C), 129.3 (2 x Ar-C), 126.0 (2 x Ar-C), 124.5 (2 x Ar-C), 115.6 (2 
x Ar-C), 38.8 (2 x CH2NH), 35.0 (2 x CH2), 25.9 (2 x CH2). 
7.1.2.11. tert-Butyl N-[2-[3-(2-hydroxy-5-nitrophenyl)propanamido]ethyl]carbamate 32. 
To a stirred solution of compound 14 (1.00 g, 5.18 mmol) in THF (50 mL), N-Boc-
ethylenediamine (0.83 g, 5.18 mmol) was added. The resulting mixture was stirred at reflux 
for 12 h. The volume of the reaction mixture was reduced and the solution was then left to 
cool overnight. The solid that crystallized was collected and dried giving compound 32 (1.39 
g, 76%) as light yellow crystals, m.p. 209-211°C. HRMS (NSI) for C16H23N3O6. Calculated 
mass of molecular ion 376.1479 [M+Na]+. Measured mass: 376.1483; IR νmax cm-1 3372, 
3340, 1684, 1584, 1540, 1488, 1326, 1278, 1252, 1159;1H-NMR (400 MHz; d6-DMSO) δH 
11.15 (1H, broad, s, OH), 7.95-7.91 (2H, m, Ar-H), 7.88 (1H, t, J = 5.5 Hz, NH), 6.95 (1H, d, 
J = 9.6 Hz, Ar-H), 6.73 (1H, t, J = 5.5 Hz, NH), 3.00 (2H, q, J = 6.2 Hz, CH2NH), 2.89 (2H, 
q, J = 6.2 Hz, CH2NH), 2.76 (2H, t, J = 7.6 Hz, CH2CH2CO), 2.49 (2H, t, J = 7.6 Hz, 
CH2CO), 1.32 (9H, s, Boc); 13C-NMR (101 MHz; d6-DMSO) δC 172.0 (C=O), 162.5 (Ar-C), 
156.1 (C=O), 139.8 (Ar-C), 129.2 (Ar-C), 126.0 (Ar-C), 124.3 (Ar-C), 115.5 (Ar-C), 78.1 
(C(CH3)3), 40.3 (CH2NH, signal obscured by d6-DMSO signal, re-appears by DEPT), 39.2 
(CH2NH), 35.0 (CH2), 28.7 (C(CH3)3), 25.9 (CH2). 
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7.1.2.12. 1-Hydroxy-N-[2-[3-(2-hydroxy-5-nitrophenyl)propanamido]ethyl]naphthalene-
2-carboxamide 34. A mixture of compound 33 (1.00 g, 3.46 mmol), phenyl-1-hydroxy-2-
naphthoate (0.92 g, 3.46 mmol) and NaHCO3 (0.29 g, 3.46 mmol) in THF/DMF (50 mL, 2:1) 
was heated at reflux for 72 h. The solvents were evaporated and the residue was recrystallized 
from ethanol/methanol (40 mL, 50:50) giving compound 34 (1.40 g, 96%) as a yellow 
powder, m.p. 232 °C. HRMS (NSI) for C22H21N3O6. Calculated mass of molecular ion 
446.1323 [M+Na]+. Measured mass: 446.1321; IR νmax cm-1 3368, 3300-2500, 1640, 1581, 
1538, 1333, 1276, 1285, 1253, 756; 1H-NMR (400 MHz; d6-DMSO) δH 9.22 (1H, m, NH), 
8.30-8.22 (2H, m, NH, Ar-H), 8.01-7.90 (3H, m, Ar-H), 7.87 (1H, d, J = 8.2 Hz, Ar-H), 7.66-
7.60 (1H, m, Ar-H), 7.57-7.52 (1H, m, Ar-H), 7.37 (1H, d, J = 8.7 Hz, Ar-H), 7.04 (1H, d, J 
= 9.2 Hz, Ar-H), 3.40 (2H, q, J = 6.4 Hz, CH2NH), 3.30 (2H, q, J = 6.0 Hz, CH2NH), 2.84 
(2H, t, J = 7.8 Hz, CH2), 2.43 (2H, t, J = 7.8 Hz, CH2); 13C-NMR (101 MHz; d6-DMSO) δC 
172.3 (C=O), 171.1 (C=O), 163.3 (Ar-C), 160.2 (Ar-C), 139.3 (Ar-C), 136.3 (Ar-C), 129.2 (2 
x Ar-C), 128.0 (Ar-C), 126.2 (Ar-C), 126.0 (Ar-C), 125.3 (Ar-C), 124.4 (Ar-C), 123.5 (Ar-
C), 123.4 (Ar-C), 117.9 (Ar-C), 115.6 (Ar-C), 107.6 (Ar-C), 39.6 (CH2NH, signal obscured 
by d6-DMSO signal, re-appears by DEPT), 38.6 (CH2), 35.1 (CH2), 26.0 (CH2).  
7.1.3. Synthesis of Aminophenols 11, 29 and 35.   
7.1.3.1. General Procedure for Lithium Formate Reductions. To a stirred solution of the 
appropriate compound 15 (1 equiv.) in either THF or THF/ethanol, was added lithium 
formate (6 equiv. per nitro-group) and 10% palladium on activated carbon catalyst.  The 
mixture was stirred at reflux for 1 h in air unless otherwise stated. The reaction was 
monitored by spotting the reaction mixture periodically onto filter paper and observing the 
disappearance (2–8 h) of the yellow colour associated with compound 15. The reaction 
mixture was then filtered rapidly while hot and the filtrate was allowed to cool and kept 
overnight. If the product had crystallized, it was collected. Alternatively, the solvent volume 
was reduced or completely evaporated and the crude product was recrystallized from an 
appropriate solvent.   
7.1.3.1.1 Ethyl 3-(5-Amino-2-hydroxyphenyl)propanoate 11a. Reduction of compound 
15a (1.00 g, 4.18 mmol) with lithium formate (1.76 g, 25.08 mmol) and 10% Pd/C (0.30 g) in 
THF (40 mL) gave compound 11a (0.58 g, 66%) as light brown crystals after evaporation of 
the solvent and recystallization of the residue from ethanol, m.p. 142-143 °C, lit. m.p. 144 
°C.16 LRMS (ES) for C11H15NO3. Calculated mass of molecular ion 210.25 [M+H]+. 
Measured mass: 209.96; IR νmax cm-1 3350, 3300-2700, 1715, 1455, 1189, 931, 864; 1H-
NMR (400 MHz; d6-DMSO) δH 8.34 (1H, s, OH), 6.48 (1H, d, J = 8.24 Hz, Ar-H), 6.32 (1H, 
d, J = 2.3, Ar-H), 6.26 (1H, dd, J = 8.2 and 2.8 Hz, Ar-H), 4.35 (2H, s, broad, NH2), 4.04 
(2H, q, J = 7.2 Hz, CH2CH3), 2.65 (2H, t, J = 7.6 Hz, CH2CH2CO), 2.48 (2H, t, J = 7.6 Hz, 
CH2CO), 1.17 (3H, t, J = 7.1 Hz, CH3); 13C-NMR (101 MHz; d6-DMSO) δC 173.1 (C=O), 
146.5 (Ar-C), 141.2 (Ar-C), 127.3 (Ar-C), 116.5 (Ar-C), 116.0 (Ar-C), 113.5 (Ar-C), 60.2 
(CH2CH3), 34.3 (CH2), 26.4 (CH2), 14.7 (CH3).  
 
7.1.3.1.2. Ethyl 3-(5-Amino-3-bromo-2-hydroxyphenyl)propanoate 11b. A mixture of 
compound 15b (2.00 g, 6.29 mmol) and tin(II) chloride dihydrate (7.15 g, 37.70 mmol) in 
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ethanol (80 mL) was heated at reflux for 3 h. The mixture was allowed to cool to rt and then 
neutralised by the addition concentrated aqueous sodium hydroxide solution. The mixture 
was filtered the filtrate was evaporated. The resulting oily residue was then stirred with 
diethyl ether (40 mL) overnight and then filtered. The filtrate was evaporated giving 
compound 11b (1.62 g, 89%) as a light orange oil which crystallized on standing, m.p. 60-62 
°C. HRMS (NSI) for C11H14BrNO3. Calculated mass of molecular ion 288.0230 [M+H]+. 
Measured mass: 288.0237; IR νmax cm-1 3318, 3300-2600, 1698, 1475, 1445, 1175; 1H-NMR 
(400 MHz; d6-DMSO) δH 9.67 (1H, s, broad, OH), 9.44 (2H, broad, s, NH2), 7.33 (1H, d, J = 
2.3 Hz, Ar-H), 7.05 (1H, d, J = 2.3 Hz, Ar-H), 4.05 (2H, q, J = 7.9 Hz, CH2O), 2.88 (2H, t,  J 
= 7.6 Hz, CH2CH2CO), 2.56 (2H, t, J = 7.6 Hz, CH2CCO), 1.17 (3H, t, J = 7.1 Hz, CH3); 13C-
NMR (101 MHz; d6-DMSO) δC 172.6 (C=O), 150.9 (Ar-C), 131.6 (Ar-C), 126.7 (Ar-C), 
124.7 (Ar-C), 123.5 (Ar-C), 112.0 (Ar-C), 60.5 (CH2CH3), 33.6 (CH2), 26.5 (CH2), 14.7 
(CH3). 
7.1.3.1.3 3-(5-Amino-2-hydroxyphenyl)-N-(2H-1,3-benzodioxol-5-yl)propanamide 11c.  
Reduction of compound 15c (1.00 g, 3.03 mmol) with lithium formate (1.27 g, 18.16 mmol) 
and 10% Pd/C (0.40 g) in THF (30 mL) gave compound 11c (0.80 g, 88%) as a light brown 
powder, m.p. 153-155 °C.  HRMS (NSI) for C16H16N2O4. Calculated mass of molecular ion 
301.1183 [M+H]+. Measured mass: 301.1185; IR νmax cm-1 3420, 3300-2800, 1649, 1498, 
1447, 1213, 1039, 794, 723; 1H-NMR (270 MHz; d6-DMSO) δH 9.85 (1H, s, NH), 8.38 (1H, 
broad, s, OH), 7.37 (1H, d, J = 2.0 Hz, Ar-H), 7.00 (1H, dd, J = 8.4 and 2.2 Hz, Ar-H), 6.88 
(1H, d, J = 8.4 Hz, Ar-H), 6.55 (1H, d, J = 8.4 Hz, Ar-H), 6.42 (1H, d, J = 2.7 Hz, Ar-H), 
6.31(1H, dd, J = 8.4 and 2.7 Hz, Ar-H), 6.02 (2H, s, CH2O), 4.39 (2H, broad, s, NH2), 2.75 
(2H, t, J = 7.8 Hz, CH2CH2CO), 2.54 (2H, m, CH2CO); 13C-NMR (68 MHz; d6-DMSO) δH 
171.2 (C=O), 147.5 (Ar-C), 146.5 (Ar-C), 143.2 (Ar-C), 141.3 (Ar-C), 134.3 (Ar-C), 128.1 
(Ar-C), 116.6 (Ar-C), 116.1 (Ar-C), 113.5 (Ar-C), 112.4 (Ar-C), 108.5 (Ar-C), 101.9 (Ar-C), 
101.4 (CH2O), 37.2 (CH2), 26.5 (CH2).  
7.1.3.1.4. 3-(5-Amino-2-hydroxyphenyl)-N-(3,4-dimethoxyphenyl)propanamide 11d.  
Reduction of the compound 15d (1.00 g, 2.89 mmol) with lithium formate (1.22 g, 17.32 
mmol) and 10% Pd/C (0.30 g) in THF (50 mL) gave compound 11d (0.61 g, 67%) as brown 
crystals, m.p. 146-148 °C. HRMS (NSI) for C17H20N2O4. Calculated mass of molecular ion 
317.1496 [M+H]+. Measured mass: 317.1500; IR νmax cm-1 3341, 3300-2700, 1652, 1513, 
1461, 1402, 1214, 1133, 742; 1H-NMR (400 MHz; d6-DMSO) δH 9.75 (1H, s, NH), 8.33 (1H, 
s, OH), 7.32 (1H, d, J = 2.8 Hz, Ar-H), 7.10 (1H, dd, J = 8.7 and 2.4 Hz, Ar-H), 6.87 (1H, d, 
J = 9.2 Hz, Ar-H), 6.51 (1H, d, J = 8.2  Hz, Ar-H), 6.38 (1H, d, J = 2.3 Hz, Ar-H), 6.27 (1H, 
dd, J = 8.2 and 2.8 Hz,  Ar-H), 4.35 (2H, s, broad, NH2), 3.72 (2 x 3H, d, J = 5.0 Hz, 2 x 
CH3), 2.71 (2H, t, J = 7.6 Hz, CH2CH2CO), 2.51 (2H, m, CH2CO); 13C-NMR (101 MHz; d6-
DMSO) δC 171.5 (C=O), 149.0 (Ar-C), 146.5 (Ar-C), 145.1 (Ar-C), 141.2 (Ar-C), 133.5 (Ar-
C), 128.1 (Ar-C), 116.6 (Ar-C), 116.1 (Ar-C), 113.4 (Ar-C), 112.6 (Ar-C), 111.5 (Ar-C), 
104.9 (Ar-C), 56.2 (CH3), 55.8 (CH3), 37.1 (CH2), 26.6 (CH2).  
7.1.3.1.5. 3-(5-Amino-2-hydroxyphenyl)-N-(4-hydroxyphenyl)propanamide 11f. 
Reduction of compound 15e (0.45 g, 1.15 mmol) with lithium formate (0.48 g, 6.90 mmol) 
and 10% Pd/C (0.15 g) in THF (25 mL) gave compound 11f (0.25 g, 80%) as a brown 
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powder, m.p. 112-114 °C. LRMS (ES) for C15H16N2O3. Calculated mass of molecular ion 
273.30 [M+H]+. Measured mass: 273.31; IR νmax cm-1 3319, 3200-2900, 1738, 1640, 1586, 
1370, 1209, 789; 1H-NMR (270 MHz; d6-DMSO) δH 9.61 (1H, s, NH), 9.14 (1H, s, OH), 
8.31 (1H, s, OH), 7.35 (2H, m, Ar-H), 6.66 (2H, m, Ar-H), 6.48 (1H, d, J = 8.4 Hz, Ar-H), 
6.35 (1H, d, J = 2.7 Hz, Ar-H), 6.24 (3H, dd, J = 8.4 and 2.7 Hz, Ar-H), 4.35 (2H, broad, s, 
NH2), 2.68 (2H, t, J = 7.7 Hz, CH2CH2CO), 2.45  (2H, m, CH2CO); 13C-NMR (68 MHz; d6-
DMSO) δC 170.9 (C=O), 153.7 (Ar-C), 146.5 (Ar-C), 141.3 (Ar-C), 131.6 (Ar-C), 128.3 (Ar-
C), 121.5 (2 x Ar-C), 116.6 (Ar-C), 116.2 (Ar-C), 115.5 (2 x Ar-C), 113.4 (Ar-C), 37.1 
(CH2), 26.6 (CH2).  
7.1.3.1.6. (S)-Methyl 2-[3-(5-Amino-2-hydroxyphenyl)propanamido]-2-phenyl-2-
carboxylate 11g. Reduction of compound 15g (0.6 g, 1.67 mmol) with lithium formate (0.7 
g, 10.00 mmol) and 10% Pd/C (0.15 g) in THF (30 mL) gave compound 11g (0.50 g, 91%) as 
pink crystals, m.p. 175-177 °C. HRMS (NSI) for C18H20N2O4. Calculated mass of molecular 
ion 329.1496 [M+H]+. Measured mass: 329.1491; IR νmax cm-1 3318, 3300-2700, 1737, 1644, 
1515, 1207, 696; 1H-NMR (270 MHz; d6-DMSO) δH 8.70 (1H, d, J = 7.2 Hz, NH), 8.26 (1H, 
s, OH), 7.36 (5H, m, Ar-H), 6.46 (1H, d, J = 8.4 Hz, Ar-H), 6.32 (1H, d, J = 2.7 Hz, Ar-H), 
6.23 (1H, dd, J = 8.2 and 2.7 Hz, Ar-H), 5.41 (1H, d, J = 7.2 Hz, CH), 4.30 (2H, broad, s, 
NH2),  3.61 (3H, s, CH3), 2.79 (2H, m, CH2CH2CO), 2.51 (2H, t, J = 9.40 Hz, CH2CO); 13C-
NMR (68 MHz; d6-DMSO) δC 172.7 (C=O), 171.8 (C=O), 146.5 (Ar-C), 141.3 (Ar-C), 136.9 
(Ar-C), 129.2 (Ar-C), 128.8 (Ar-C), 128.4 (Ar-C), 128.2 (Ar-C), 116.5 (Ar-C), 116.1 (Ar-C), 
113.4 (Ar-C), 56.8 (CHNH), 52.8 (CH3), 35.6 (CH2), 26.5 (CH2). 
7.1.3.1.7. 3-(5-Amino-2-hydroxyphenyl)-N-(4-pyridylmethyl)propanamide 11h. 
Reduction of compound 15h (1.0 g, 3.32 mmol) with lithium formate (1.40 g, 19.90 mmol) 
and 10% Pd/C (0.45 g) in THF/EtOH (8:1, 45 mL) gave compound 11h (0.88 g, 98%) as a 
brown oil after evaporation of the solvent. The oil gradually crystallized on standing giving a 
brown solid, m.p. 114-116 °C. HRMS (NSI) for C15H17N3O2. Calculated mass of molecular 
ion 272.1394 [M+H]+. Measured mass: 272.1393; IR νmax cm-1 3309, 3300-2700, 1638, 1542, 
1505, 1421, 1216; 1H-NMR (270 MHz; d6-DMSO) δH 8.60-8.30 (4H, m, NH, OH, 2 x Ar-H), 
7.13 (2H, d, J = 5.7 Hz, Ar-H), 6.49 (1H, d, J = 5.7 Hz, Ar-H), 6.34 (1H, d, J = 2.7 Hz, Ar-
H), 6.27 (1H, dd, J = 8.2 and 2.6 Hz, Ar-H), 4.5-4.27 (2H, broad, s, NH2),  4.26 (2H, d, J = 
5.9 Hz, CH2NH), 2.67 (2H, t, J = 7.6 Hz, CH2CH2CO), 2.40 (2H, t, J = 7.6 Hz, CH2CO); 13C-
NMR (68 MHz; d6-DMSO) δC 172.9 (C=O), 150.0 (2 x Ar-C), 149.2 (Ar-C), 146.6 (Ar-C), 
141.3 (Ar-C), 128.1 (Ar-C), 122.6 (Ar-C), 116.7 (Ar-C), 116.2 (Ar-C), 113.4 (Ar-C), 41.6 
(CH2NH), 36.2 (CH2), 26.8 (CH2).  
7.1.3.1.8. 3-(5-Amino-2-hydroxyphenyl)-N-(3-imidazol-1-ylpropyl)propanamide 11i.  
Reduction of compound 15i (1.6 g, 5.03 mmol) with lithium formate (2.1 g, 30.10 mmol) and 
10% Pd/C (0.45 g) in THF/EtOH (8:1, 45 mL) gave compound 11i (1.26 g, 87%) as a brown 
solid, m.p. 125-126 °C. LRMS (E.S) for C15H20N4O2. Calculated mass of molecular ion 
295.28 [M+Li]+. Measured mass: 295.22; IR νmax cm-1 3401, 3280, 3100-2500, 1660, 1511, 
1436, 1227, 1084, 827; 1H -NMR (400 MHz; d6-DMSO) δH 8.32 (1H, broad, s, OH), 7.88 
(1H, t, J = 5.5 Hz, NH), 7.60 (1H, s, Ar-H), 7.16 (1H, s, Ar-H), 6.88 (1H, s, Ar-H), 6.47 (1H, 
d, J = 8.2 Hz, Ar-H), 6.32 (1H, d, J = 2.8 Hz, Ar-H), 6.25 (1H, dd, J = 8.2 and 2.8 Hz, Ar-H), 
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4.33 (2H, s, broad, NH2), 3.90 (2H, t, J = 6.9 Hz, CH2CH2CH2NH), 2.99 (2H, q, J = 6.9 Hz, 
CH2CH2CH2NH), 2.62 (2H, t, J = 7. Hz, CH2), 2.30 (2H, t,  J = 7.6 Hz, CH2), 1.79 (2H, p, J 
= 6.9 Hz, CH2CH2CH2NH); 13C-NMR (101 MHz; d6-DMSO) δC 172.6 (C=O), 146.4 (Ar-C), 
141.2 (Ar-C), 137.8 (Ar-C), 128.9 (Ar-C), 128.3 (Ar-C), 119.9 (Ar-C), 116.5 (Ar-C), 116.1 
(Ar-C), 113.3 (Ar-C), 44.1 (CH2), 36.3 (CH2), 36.2 (CH2), 31.3 (CH2), 26.6 (CH2).    
 
7.1.3.1.9. 3-(5-Amino-2-hydroxyphenyl)-N-[4-[3-(5-amino-2-
hydroxyphenyl)propanamido]phenyl]propanamide 29a. Reduction of compound 28a 
(1.00 g, 2.02 mmol) with lithium formate (0.85 g, 12.13 mmol) and 10% Pd/C (0.70 g) in 
THF/DMF (30 mL, 2:1) gave compound 29a (0.60 g, 68%) as a brown powder, m.p. > 220 
°C. HRMS (NSI) for C24H26N4O4. Calculated mass of molecular ion 435.2027 [M+H]+. 
Measured mass: 435.2028; IR νmax cm-1 3280, 3200-2500, 1657, 1544, 1512, 1401, 1217, 
812, 704; 1H-NMR (400 MHz; d6-DMSO) δH 9.77 (2H, s, 2 x NH), 8.28 (2H, broad, s, 2 x 
OH), 7.46 (4H, s, Ar-H), 6.45 (2H, d, J = 8.2 Hz, Ar-H), 6.33 (2H, d, J =  2.8 Hz, Ar-H), 6.22 
(2H, dd, J = 8.2 and 2.8 Hz, Ar-H), 4.33 (4H, broad, s, 2 x NH2), 2.66 (4H, t, J = 7.8 Hz, 2 x 
CH2CH2CO), 2.46 (4H, m, 2 x CH2CO); 13C-NMR (101 MHz; d6-DMSO) δC 171.2 (2 x 
C=O), 146.5 (2 x Ar-C), 141.2 (2 x Ar-C), 135.1 (2 x Ar-C), 128.1 (2 x Ar-C), 120.0 (4 x Ar-
C), 116.6 (2 x Ar-C), 116.1 (2 x Ar-C), 113.5 (2 x Ar-C), 37.1 (2 x CH2), 26.5 (2 x CH2).  
7.1.3.1.10. 3-(5-Amino-2-hydroxyphenyl)-N-[2-[3-(5-amino-2-
hydroxyphenyl)propanamido]ethyl]propanamide 29b. Reduction of compound 28b (1.30 
g, 2.91 mmol) with lithium formate (1.22 g, 17.44 mmol) and 10% Pd/C (0.80 g) in 
THF/DMF (50 mL, 2:1) gave compound 29b (0.85 g, 75.5%) as a dark powder, m.p. 243-244 
°C. LRMS (ES) for C20H26N4O4. Calculated mass of molecular ion 387.44 [M+H]+. 
Measured mass: 387.06; IR νmax cm-1 3317, 3200-2500, 1634, 1565, 1286, 1238; 1H-NMR 
(400 MHz; d6-DMSO) δH 8.08-8.01 (2H, m, 2 x NH), 7.81-7.77 (4H, m, Ar-H), 6.32 (2H, d, J 
= 8.7 Hz, Ar-H), 3.92 (4H, broad, s, 2 x NH2), 3.09-3.03 (4H, m, 2 x CH2NH), 2.67 (4H, t, J 
= 7.6 Hz, 2 x CH2CH2CO), 2.33 (4H, t, J = 7.6 Hz, 2 x CH2CO); 13C-NMR (101 MHz; d6-
DMSO) δC 174.9 (2 x C=O), 172.8 (2 x Ar-C), 131.4 (2 x Ar-C), 130.2 (2 x Ar-C), 126.0 (2 x 
Ar-C), 125.9 (2 x Ar-C), 117.9 (2 x Ar-C), 38.9 (2 x CH2NH), 35.9 (2 x CH2), 26.6 (2 x 
CH2). 
7.1.3.1.11. 1-Hydroxy-N-[2-[3-(5-amino-2-
hydroxyphenyl)propanamido]ethyl]naphthalene-2-carboxamide 35.   Compound 34 
(0.90 g, 2.13 mmol) was reduced with lithium formate (0.90 g, 12.78 mmol) and 10% Pd/C 
(0.50 g) in THF/DMF (50 mL 2:1) under a nitrogen atmosphere. The reaction mixture was 
rapidly filtered and the solvent evaporated affording compound 35 (0.60 g, 72%) as a dark 
powder which was used directly in the synthesis of compound 36 without further 
characterisation.       
       
7.1.4. Synthesis of Boc-protected amino acids 16, 17, 30 and 36.           
7.1.4.1. General procedure. The appropriate amine 11 (1 equiv. or 0.5 equiv. in the case of 
compounds 30) was dissolved in dry THF or DMF and cooled to -5 °C in an ice/salt bath. In 
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a separate flask, to a stirred solution of Boc-L-alanine or Boc-β-alanine (1.05 equiv.) in dry 
THF and/or DMF was added N-methylmorpholine (1 equiv.) and the mixture was cooled to -
5 °C.  Isobutyl chloroformate (IBCF) (1 equiv.) was then added to this mixture and after 
stirring for 90 seconds at -5 °C, the previously prepared Boc-amino acid solution was added. 
The resulting mixture was stirred at -5 °C for 1 h and then at rt overnight. The solvent was 
evaporated and the residue was dissolved in either dichloromethane or ethyl acetate. The 
organic phase was washed sequentially with 0.1 M citric acid solution, 10% aqueous sodium 
hydrogen carbonate solution and water. The organic layer was dried (MgSO4) and evaporated 
giving the product.  
7.1.4.1.1. Ethyl 3-(5-Amino-2-hydroxyphenyl)propanoate; Boc L-alanine derivative 16a. 
Compound 16a was synthesized from compound 11a (0.21 g, 1.00 mmol), Boc-L-alanine 
(0.20 g, 1.05 mmol), N-methylmorpholine (0.10 g, 1.00 mmol) and IBCF (0.14 g, 1.00 mmol) 
in dry THF (20 mL). No further purification of the product was required. Yield: (0.31 g, 
81%) of an orange solid, m.p. 70-72 °C.  HRMS (NSI) for C19H28N2O6. Calculated mass of 
molecular ion 381.2020 [M+H]+. Measured mass: 381.2020; IR νmax cm-1 3319, 3300-3100, 
1745, 1657, 1507, 1438, 1232, 1161; 1H-NMR (400 MHz; d6-DMSO) δH 9.55 (1H, s, NH),  
9.17 (1H, s, OH), 7.24-7.18 (2H, m, Ar-H), 6.94 (1H, d, J = 7.3 Hz, NH), 6.66 (1H, d, J = 8.7 
Hz, Ar-H), 4.05-3.96 (3H, m, CH2O, CH), 2.69  (2H, t, J = 7.6 Hz, CH2CH2CO), 2.51-2.44 
(2H, m, CH2CO), 1.33 (9H, s, 3 x CH3), 1.18 (3H, d, J = 7.3 Hz, CH3), 1.12 (3H, t, J = 7.1 
Hz, CH3); 13C-NMR (101 MHz; d6-DMSO) δC 172.9 (C=O), 171.6 (C=O), 155.6 (C=O), 
151.6 (Ar-C), 131.2 (Ar-C), 126.9 (Ar-C), 121.8 (Ar-C), 119.2 (Ar-C), 115.2 (Ar-C), 78.5 
(C(CH3)3),  60.3 (CH2CH3), 50.7 (CHCH3), 34.0 (CH2), 28.7 (C(CH3)3), 26.3 (CH2), 18.7 
(CHCH3), 14.6 (CH2CH3).  
7.1.4.1.2. Ethyl 3-(5-Amino-3-bromo-2-hydroxyphenyl)propanoate; Boc L-alanine 
derivative  16b. Compound 16b was synthesized from compound 11b (0.58 g, 2.00 mmol), 
Boc-L-alanine (0.40 g, 2.10 mmol), N-methylmorpholine (0.20 g, 2.00 mmol) and IBCF (0.28 
g, 2.00 mmol) in dry THF (30 mL). No further purification was required. Yield: (0.70 g, 
76%) as an orange solid, m.p. 47 °C. HRMS (NSI) for C19H27BrN2O6. Calculated mass of 
molecular ion 459.1125 [M+H]+. Measured mass: 459.1133; IR νmax cm-1 3360, 3306, 2978, 
1673, 1479, 1249, 1159; 1H-NMR (400 MHz; d6-DMSO) δH 9.81 (1H, s, NH),  8.87 (1H, s, 
OH), 7.78 (1H, d, J = 2.3 Hz,  Ar-H), 7.23 (1H, d, J = 2.1 Hz, Ar-H), 7.07 (1H, d, J = 7.3 Hz, 
NH), 4.07-4.01 (3H, m, CH2O, CH), 2.83 (2H, t, J = 7.6 Hz, CH2),  2.54 (2H, t, J = 7.6 Hz, 
CH2), 1.38 (9H, s, 3 x CH3), 1.22 (3H, d, J = 6.9 Hz, CH3), 1.16 (3H, t, J = 7.3 Hz, CH3); 13C-
NMR (101 MHz; d6-DMSO) δC 172.7 (C=O), 172.1 (C=O), 155.7 (C=O), 147.8 (Ar-C), 
132.9 (Ar-C), 130.6 (Ar-C), 121.7 (Ar-C), 120.8 (Ar-C), 111.6 (Ar-C), 78.6 (C(CH3)3), 60.4 
(CH2CH3), 50.9 (CHCH3), 33.9 (CH2), 28.5 (C(CH3)3), 26.8 (CH2), 18.5 (CHCH3), 14.6 
(CH2CH3).  
7.1.4.1.3. 3-(5-Amino-2-hydroxyphenyl)-N-(2H-1,3-benzodioxol-5-yl)propanamide; Boc 
L-alanine derivative 16c. Compound 16c was synthesized from compound 11c (0.30 g, 1.00 
mmol), Boc-L-alanine (0.20 g, 1.05 mmol), N-methylmorpholine (0.10 g, 1.00 mmol) and 
IBCF (0.14 g, 1.00 mmol) in dry THF (20 mL). No further purification was required. Yield: 
(0.45 g, 95.5%) of white flakes, m.p. 178-179 °C. HRMS (NSI) for C24H29N3O7. Calculated 
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mass of molecular ion 472.2078 [M+H]+. Measured mass: 472.2076; IR νmax cm-1 3316, 
3300-2750, 1678, 1504, 1234, 1183, 866, 798; 1H-NMR (400 MHz; d6-DMSO) δH 9.86 (1H, 
s, NH), 9.63 (1H, s, NH), 9.23 (1H, broad, s, OH), 7.32 (2H, d, J = 1.3 Hz, Ar-H), 7.25 (1H, 
dd, J = 8.7 and 2.8 Hz, Ar-H), 7.00 (1H, d, J = 7.8 Hz, NHCH), 6.95 (1H, dd, J = 8.2 and 1.8 
Hz, Ar-H), 6.83 (1H, d, J = 8.2 Hz, Ar-H), 6.73 (1H, d, J = 8.7 Hz, Ar-H), 5.97 (2H, s, 
CH2O), 4.07 (1H, p, J = 7.3 Hz, CH) 2.78 (2H, t, J = 8.0 Hz, CH2CH2CO), 2.53 (2H, m, 
CH2CO), 1.38 (9H, s, 3 x CH3), 1.23 (3H, d, J = 7.3 Hz, CH3); 13C-NMR (68 MHz; d6-
DMSO) δC 171.6 (C=O), 170.9 (C=O), 155.7 (C=O), 151.9 (Ar-C), 147.5 (Ar-C), 143.2 (Ar-
C), 134.3 (Ar-C), 131.1 (Ar-C), 127.8 (Ar-C), 121.9 (Ar-C), 119.1 (Ar-C), 115.3 (Ar-C), 
112.5 (Ar-C), 108.5 (Ar-C), 102.0 (Ar-C), 101.4 (CH2O), 78.5 (C(CH3)3), 50.8 (CHCH3), 
36.9 (CH2), 28.8 (C(CH3)3), 26.5 (CH2), 18.8 (CHCH3).  
7.1.4.1.4. 3-(5-Amino-2-hydroxyphenyl)-N-(3,4-dimethoxyphenyl)propanamide; Boc L-
alanine derivative 16d. Compound 16d was synthesized from compound 11d (0.32 g, 1.00 
mmol), Boc-L-alanine (0.20 g, 1.05 mmol), N-methylmorpholine (0.10 g, 1.00 mmol) and 
IBCF (0.14 g, 1.00 mmol) in dry THF (20 mL). No further purification was required. Yield: 
(0.40 g, 81%) of light brown crystals, m.p. 86-88 °C. HRMS (NSI) for C25H33N3O7. 
Calculated mass of molecular ion 488.2391 [M+H]+. Measured mass: 488.2391; IR νmax cm-1 
3281, 3250-2800, 1660, 1510, 1229, 1161, 1023; 1H-NMR (400 MHz; d6-DMSO) δH 9.77 
(1H, s, NH), 9.61 (1H, s, broad, OH), 9.21 (1H, s, NH),  7.36-7.23 (3H, m, Ar-H, NH), 7.08 
(1H, dd, J = 8.7 and 1.8 Hz, Ar-H), 6.98 (1H, d, J = 7.3 Hz, Ar-H), 6.86 (1H, d, J = 8.7 Hz, 
Ar-H), 6.72 (1H, d, J = 8.7 Hz, Ar-H), 4.03 (1H, p, J = 6.6 Hz, CH), 3.68 (2 x 3H, d, J = 4.6 
Hz, 2 x CH3), 2.79 (2H, t, J = 7.8 Hz, CH2), 2.51 (2H, m, CH2), 1.38 (9H, s, 3 x CH3), 1.22 
(3H, t, J = 6.9 Hz, CH3); 13C-NMR (101 MHz; d6-DMSO) δC 171.6 (C=O), 170.8 (C=O), 
155.6 (C=O), 151.6 (Ar-C), 149.0 (Ar-C), 145.1 (Ar-C), 133.5 (Ar-C), 131.2 (Ar-C), 127.8 
(Ar-C), 121.9 (Ar-C), 119.1 (Ar-C), 115.2 (Ar-C), 112.5 (Ar-C), 111.5 (Ar-C), 104.9 (Ar-C), 
78.5 (C(CH3)3), 56.2 (CH3O), 55.8 (CH3O), 50.7 (CHCH3), 36.9 (CH2), 28.7 (C(CH3)3), 26.5 
(CH2), 18.8 (CHCH3).  
7.1.4.1.5. 3-(5-Amino-2-hydroxyphenyl)-N-(4-hydroxyphenyl)propanamide; Boc L-
alanine derivative 16f.  Compound 16f was synthesized from compound 11f (0.60 g, 2.20 
mmol), Boc-L-alanine (0.44 g, 2.30 mmol), N-methylmorpholine (0.22 g, 2.20 mmol) and 
IBCF (0.30 g, 2.20 mmol) in dry THF/DMF (25 mL, 4:1). No further purification was 
required. Yield: (0.45 g, 46%) of a white powder, m.p. 102-104 °C. LRMS (ES) for 
C23H29N3O6. Calculated mass of molecular ion 466.48 [M+Na]+. Measured mass: 466.19; IR 
νmax cm-1 3220, 3200-2470, 1651, 1510, 1227, 1112, 834; 1H-NMR (400 MHz; d6-DMSO) δH 
9.65 (1H, s, NH), 9.60 (1H, s, NH), 9.19 (1H, s, broad, OH), 9.15 (1H, broad s, OH), 7.39-
7.30 (3H, m, Ar-H), 7.25 (1H, dd, J = 8.5 and 2.5 Hz, Ar-H), 6.99 (1H, d, J = 7.3 Hz, 
NHCH), 6.72-6.65 (3H, m, Ar-H), 4.07 (1H, p, J = 6.9 Hz, CHNH), 2.78 (2H, t, J = 7.8 Hz, 
CH2), 2.50 (2H, m, CH2), 1.38 (9H, s, 3 x CH3), 1.23 (3H, d, J = 6.9 Hz, CH3); 13C-NMR 
(101 MHz; d6-DMSO) δH 171.6 (C=O), 170.5 (C=O), 155.6 (C=O), 153.6 (Ar-C), 151.6 (Ar-
C), 131.5 (Ar-C), 131.2 (Ar-C), 127.9 (Ar-C), 121.9 (Ar-C), 121.5 (2 x Ar-C), 119.0 (Ar-C), 
115.5 (2 x Ar-C), 115.2 (Ar-C), 78.5 (C(CH3)3), 50.74 (CHCH3), 36.8 (CH2), 28.7 (C(CH3)3), 
26.6 (CH2), 18.8 (CHCH3). 
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7.1.4.1.6. (S)-Methyl 2-[3-(5-Amino-2-hydroxyphenyl)propanamido]-2-phenyl-2-
carboxylate; Boc L-alanine derivative 16g. Compound 16g was synthesized from 
compound 11g (0.33 g, 1.00 mmol), Boc-L-alanine (0.20 g, 1.05 mmol), N-methylmorpholine 
(0.10 g, 1.00 mmol) and IBCF (0.14 g, 1.00 mmol) in dry THF (20 mL). No further 
purification was required. Yield: (0.45 g, 89%) of pale pink crystals, m.p. 82-84 °C. HRMS 
(NSI) for C26H33N3O7. Calculated mass of molecular ion 500.2391 [M+H]+. Measured mass: 
500.2394; IR νmax cm-1 3304, 3300-2800, 1651, 1498, 1366, 1230, 1160, 1022, 697; 1H-NMR 
(400 MHz; d6-DMSO) δH 9.59 (1H, s, NH), 9.16 (1H, s, OH), 8.73 (1H, d, J = 6.9 Hz, NH), 
7.42-7.32 (5H, m, Ar-H), 7.25 (2H, m, Ar-H), 6.98 (1H, d, J = 7.3 Hz, NH), 6.69 (1H, d, J = 
8.7 Hz, Ar-H), 5.42 (1H, d, J = 7.3 Hz, CH), 4.08 (1H, p, J = 7.1 Hz, CH),  3.62 (3H, s, CH3), 
2.70 (2H, m, CH2), 2.44 (2H, t, J = 7.6 Hz, CH2), 1.38 (9H, s, 3 x CH3), 1.23 (3H, d, J = 7.3 
Hz, CH3); 13C-NMR (68 MHz; d6-DMSO) δC 172.4 (C=O), 171.7 (C=O), 171.5 (C=O), 155.6 
(C=O), 151.5 (Ar-C), 136.8 (Ar-C), 131.2 (Ar-C), 129.2 (2 x Ar-C), 128.7 (Ar-C), 128.3 (2 x 
Ar-C), 127.8 (Ar-C), 121.9 (Ar-C), 119.0 (Ar-C), 115.2 (Ar-C), 78.5 (C(CH3)3), 56.8 
(CHNH), 52.7 (CH3), 50.7 (CHCH3), 35.4 (CH2), 28.6 (C(CH3)3), 26.5 (CH2), 18.8 (CHCH3). 
7.1.4.1.7. 3-(5-Amino-2-hydroxyphenyl)-N-(4-pyridylmethyl)propanamide; Boc L-
alanine derivative 16h. Compound 16h was synthesized from compound 11h (0.27 g, 1.00 
mmol), Boc-L-alanine (0.20 g, 1.05 mmol), N-methylmorpholine (0.10 g, 1.00 mmol) and 
IBCF (0.14 g, 1.00 mmol) in dry THF/DMF (20 mL, 3:1). No further purification was 
required. Yield: (0.30 g, 68%) as a pale pink powder, m.p. 115-117 °C. LRMS (ES) for 
C23H30N4O5. Calculated mass of molecular ion 465.50 [M+Na]+. Measured mass: 465.16; IR 
νmax cm-1 3294, 3200-2550, 1644, 1505, 1232, 1193, 1111; 1H-NMR (400 MHz; d6-DMSO) 
δH 9.61(1H, s, NH),  9.18 (1H, broad,s, OH), 8.46-8.41 (3H, m, NHCH2, 2 x Ar-H), 7.31-7.26 
(2H, m, Ar-H), 7.12 (2H, d, J = 6.0 Hz, Ar-H), 6.99 (1H, d, J = 7.3 Hz, NHCH), 6.71 (1H, d, 
J = 9.2 Hz, Ar-H), 4.27 (2H, d, J = 6.0 Hz, CH2NH), 4.07 (1H, p, J = 6.9 Hz, CH), 2.75 (2H, 
t, J = 7.6 Hz, CH2), 2.44 (2H, t, J = 7.8 Hz, CH2), 1.37 (9H, s, 3 x CH3), 1.22 (3H, d, J = 7.3 
Hz, CHCH3); 13C-NMR (101 MHz; d6-DMSO) δC 172.5 (C=O), 171.5 (C=O), 155.6 (C=O), 
151.6 (Ar-C), 150.0 (2 x Ar-C), 149.1 (Ar-C), 131.3 (Ar-C), 127.7 (Ar-C), 122.5 (2 x Ar-C), 
121.9 (Ar-C), 119.0 (Ar-C), 115.3 (Ar-C) 78.5 (C(CH3)3), 50.7 (CHCH3), 41.5 (CH2NH), 
35.8 (CH2), 28.7 (C(CH3)3) 26.7 (CH2), 18.8 (CH3).  
7.1.4.1.8. 3-(5-Amino-2-hydroxyphenyl)-N-(3-imidazol-1-ylpropyl)propanamide; Boc L-
alanine derivative 16i. Compound 16i was synthesized from compound 11i (0.29 g, 1.00 
mmol), Boc-L-alanine (0.20 g, 1.05 mmol), N-methylmorpholine (0.10 g, 1.00 mmol) and 
IBCF (0.14 g, 1.00 mmol) in dry THF/DMF (20 mL, 1:1). No further purification was 
required. Yield: (0.35 g, 76%) of an orange wax. LRMS (ES) for C23H33N5O5. Calculated 
mass of molecular ion 460.54 [M+H]+. Measured mass: 460.24; IR νmax cm-1 3241, 3200-
2600, 1650, 1547, 1505, 1232, 1162, 745; 1H-NMR (400 MHz; d6-DMSO) δH 9.60 (1H, 
broad, s, OH), 7.91 (1H, t, J = 5.7 Hz, NHCH2), 7.60 (1H, s, Ar-H), 7.28 (1H, s, Ar-H), 7.23 
(1H, dd, J = 8.7 and 2.8 Hz, Ar-H), 7.15 (1H, s, Ar-H), 7.08 (1H, d, J = 7.8 Hz, NH), 6.99 
(1H, d, J = 7.3 Hz, NH), 6.88 (1H, s, Ar-H), 6.70 (1H, d, J = 8.7 Hz, Ar-H), 4.06 (1H, p, J = 
7.1 Hz, CH), 3.89 (2H, t, J = 6.9 Hz, CH2CH2CH2NH), 2.98 (2H, q, J = 6.4 Hz, 
CH2CH2CH2NH), 2.70 (2H, t, J = 7.8 Hz, CH2), 2.33 (2H, t, J = 7.8 Hz, CH2), 1.79 (2H, p, J 
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= 6.9 Hz, CH2CH2CH2NH) 1.38 (9H, s, 3 x CH3), 1.22 (3H, d, J = 7.3 Hz, CH3); 13C-NMR 
(101 MHz; d6-DMSO) δC 175.2 (C=O), 172.4 (C=O), 155.8 (C=O), 151.5 (Ar-C), 137.8 (Ar-
C), 131.2 (Ar-C), 128.8 (Ar-C), 127.9 (Ar-C), 121.8 (Ar-C), 119.9 (Ar-C), 119.0 (Ar-C), 
115.3 (Ar-C), 78.4 (C(CH3)3), 50.7 (CHCH3), 44.1 (CH2), 36.1 (CH2), 36.0 (CH2), 31.2 
(CH2), 28.7 (C(CH3)3), 26.6 (CH2), 18.8 (CH3). 
7.1.4.1.9. Ethyl 3-(5-Amino-2-hydroxyphenyl)propanoate; Boc β-alanine derivative 17a. 
Compound 17a was synthesized from compound 11a (0.21 g, 1.00 mmol), Boc-β-alanine 
(0.20 g, 1.05 mmol), N-methylmorpholine (0.10 g, 1.00 mmol) and IBCF (0.14 g, 1.00 mmol) 
in dry THF (20 mL). No further purification was required. Yield: (0.30 g, 79%) as a brown 
solid, m.p. 91-93 °C. HRMS (NSI) for C19H28N2O6. Calculated mass of molecular ion 
381.2020 [M+H]+. Measured mass: 381.2023; IR νmax cm-1 3296, 3163, 2982, 1734, 1687, 
1549, 1440, 1364, 1284, 1247, 1161; 1H-NMR (400 MHz; d6-DMSO) δH 9.64 (1H, s, NH), 
9.21 (1H, s, broad, OH), 7.27 (1H, d, J = 2.3 Hz, Ar-H), 7.29 (1H, dd, J = 8.7 and 2.52 Hz, 
Ar-H), 6.86 (1H, t, J = 5.7 Hz, NHCH2), 6.68 (1H, d, J = 8.7 Hz, Ar-H), 4.04 (2H, q, J = 7.0 
Hz, CH2CH3), 3.18 (2H, q, J = 7.0 Hz, CH2NH), 2.72 (2H, m, CH2CH2CO), 2.52 (2H, m, 
CH2CO), 2.39 (2H, t, J = 7.1 Hz, CH2CH2NH), 1.38 (9H, s, 3 x CH3), 1.16 (3H, t, J = 7.1 Hz, 
CH3); 13C-NMR (101 MHz; d6-DMSO) δC 172.9 (C=O), 169.1 (C=O), 156.0 (C=O), 151.5 
(Ar-C), 131.4 (Ar-C), 126.8 (Ar-C), 121.8 (Ar-C), 119.2 (Ar-C), 115.1 (Ar-C), 78.1 
(C(CH3)3), 60.3 (CH2CH3), 37.2 (CH2), 37.1 (CH2), 34.1 (CH2), 28.8 (C(CH3)3), 26.2 (CH2), 
14.6 (CH3). 
7.1.4.1.10. Ethyl 3-(5-Amino-3-bromo-2-hydroxyphenyl)propanoate; Boc β-alanine 
derivative 17b.  Compound 17b was synthesized from compound 11b (0.58 g, 2.00 mmol), 
Boc-β-alanine (0.40 g, 2.10 mmol), N-methylmorpholine (0.20 g, 2.00 mmol) and IBCF (0.28 
g, 2.00 mmol) in dry THF (30 mL). No further purification was required. Yield: (0.60 g, 
65%) as an orange wax. HRMS (NSI) for C19H27BrN2O6. Calculated mass of molecular ion 
459.1125 [M+H]+. Measured mass: 459.1125; IR νmax cm-1 3382, 3300-2500, 2979, 1682, 
1478, 1247, 1160; 1H-NMR (400 MHz; d6-DMSO) δH 9.77 (1H, s, NH), 8.80 (1H, s, broad, 
OH), 7.72 (1H, d, J = 2.8 Hz, Ar-H), 7.15 (1H, d,  J = 2.3 Hz, Ar-H), 6.81 (1H, m, NHCH2), 
4.00 (2H, q, J = 6.9 Hz, CH2CH3), 3.15 (2H, q, J = 6.9 Hz, CH2NH), 2.78-2.73 (2H, m, CH2), 
2.50-2.46 (2H, m, CH2), 2.36 (2H, t, J = 7.1 Hz, CH2CH2NH), 1.33 (9H, s, 3 x CH3), 1.15 
(3H, t, J = 7.1 Hz, CH3); 13C-NMR (101 MHz; d6-DMSO) δC 172.7 (C=O), 169.6 (C=O), 
156.1 (C=O), 147.7 (Ar-C), 133.1 (Ar-C), 130.5 (Ar-C), 121.9 (Ar-C), 120.8 (Ar-C), 111.6 
(Ar-C), 78.1 (C(CH3)3), 60.4 (CH2CH3), 37.3 (CH2), 37.0 (CH2), 33.9 (CH2), 28.8 (C(CH3)3), 
26.8 (CH2), 14.5 (CH3). 
7.1.4.1.11. 3-(5-Amino-2-hydroxyphenyl)-N-(2H-1,3-benzodioxol-5-yl)propanamide; Boc 
β-alanine derivative 17c. Compound 17c was synthesized from compound 11c (0.30 g, 1.00 
mmol), Boc-β-alanine (0.20 g, 1.05 mmol), N-methylmorpholine (0.10 g, 1.00 mmol) and 
IBCF (0.14 g, 1.00 mmol) in dry THF (20 mL). No further purification was required. Yield: 
(0.43 g, 91.3%) as a light pink powder, m.p. 179-180 °C. HRMS (NSI) for C24H29N3O7. 
Calculated mass of molecular ion 472.2078 [M+H]+. Measured mass: 472.2068; IR νmax cm-1 
3322, 3300-2600, 2962, 1651, 1538, 1493, 1453, 1226, 1163, 1033, 797; 1H-NMR (400 
MHz; d6-DMSO) δH 9.85 (1H, s, NH), 9.66 (1H, s, NH), 9.21 (1H, broad, s, OH), 7.32 (2H, 
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d, J = 2.3 Hz, Ar-H), 7.22 (1H, dd, J = 7.1 and 2.3 Hz, Ar-H), 6.94 (1H, dd, J = 8.2 and 1.8 
Hz, Ar-H), 6.87-6.81 (2H, m, NHCH2, Ar-H), 6.70 (1H, d, J = 8.2 Hz, Ar-H), 5.97 (2H, s, 
CH2O), 3.20 (2H, q, J = 6.7 Hz, CH2NH), 2.76 (2H, t, J = 7.8 Hz, CH2CH2CO), 2.52 (2H, m, 
CH2CO), 2.39 (2H, t, J = 7.3 Hz, CH2CH2NH), 1.37 (9H, s, 3 x CH3); 13C-NMR (101 MHz; 
d6-DMSO) δC 170.9 (C=O), 160.1 (C=O), 156.0 (C=O), 151.5 (Ar-C), 147.5 (Ar-C), 143.2 
(Ar-C), 134.3 (Ar-C), 131.4 (Ar-C), 127.6 (Ar-C), 121.9 (Ar-C), 119.0 (Ar-C), 115.2 (Ar-C), 
112.4 (Ar-C), 108.5 (Ar-C), 101.9 (Ar-C), 101.4 (CH2O), 78.1 (C(CH3)3), 37.2 (CH2), 37.1 
(CH2), 36.8 (CH2), 28 .8 (C(CH3)3), 26.5 (CH2).  
7.1.4.1.12. 3-(5-Amino-2-hydroxyphenyl)-N-[4-[3-(5-amino-2-
hydroxyphenyl)propanamido]phenyl]propanamide; bis-Boc L-alanine derivative 30a. 
Compound 30a was synthesized from compound 29a (0.43 g, 1.00 mmol), Boc-L-alanine 
(0.40 g, 2.10 mmol), N-methylmorpholine (0.20 g, 2.00 mmol) and IBCF (0.28 g, 2.00 mmol) 
in dry THF:DMF (20 mL, 2:1). No further purification was required. Yield: (0.69 g, 89%) as 
a brown powder, m.p. 215-217 °C; HRMS (NSI) for C40H52N6O10. Calculated mass of 
molecular ion 794.4083 [M+NH4]+. Measured mass: 794.4085; IR νmax cm-1 3311, 3300-
2700, 1652m, 1498, 1241, 1165, 830; 1H-NMR (400 MHz; d6-DMSO) δH 9.83 (2H, s, 2 x 
NH),  9.59 (2H, s, 2 x NH),  9.18 (2H, broad, s, 2 x OH), 7.46 (4H, s, Ar-H), 7.28 (2H, m, Ar-
H), 7.20 (2H, dd, J = 8.2 and 2.5 Hz, Ar-H), 6.94 (2H, d, J = 7.3 Hz, 2 x NHCH), 6.68 (2H, 
d, J = 8.7 Hz, Ar-H), 4.03 (2H, p, J = 7.2 Hz, 2 x CH), 2.74 (4H, t, J = 7.8 Hz, 2 x 
CH2CH2CO), 2.50 (4H, t, J = 7.8 Hz, 2 x CH2CO), 1.33 (18H, s, 6 x CH3), 1.18 (6H, d, J = 
6.9 Hz, 2 x CH3); 13C-NMR (101 MHz; d6-DMSO) δC 171.6 (2 x C=O), 170.9 (2 x C=O), 
155.6 (2 x C=O), 151.6 (2 x Ar-C), 135.1 (2 x Ar-C), 131.2 (2 x Ar-C),  127.8 (2 x Ar-C), 
121.9 (2 x Ar-C), 120.0 (4 x Ar-C), 119.1 (2 x Ar-C), 115.2 (2 x Ar-C), 78.5 (2 x C(CH3)3), 
50.8 (2 x CHCH3), 36.8 (2 x CH2), 28.8 (2 x C(CH3)3), 26.5 (2 x CH2), 18.8 (2 x CH3). 
7.1.4.1.13. 3-(5-Amino-2-hydroxyphenyl)-N-[2-[3-(5-amino-2-hydroxy-
phenyl)propanamido]ethyl]propanamide; bis-Boc L-alanine derivative 30b. Compound 
30b was synthesized from compound 29b (0.77 g, 2.00 mmol), Boc-L-alanine (0.80 g, 4.20 
mmol), N-methylmorpholine (0.40 g, 4.00 mmol) and IBCF (0.56 g, 4.00 mmol) in dry THF 
(30 mL). The crude product was purified by column chromatography (eluent; CH2Cl2/EtOH, 
9:1) giving compound 30b (0.46 g, 31.6%) as an orange solid, m.p. 65 °C. HRMS (NSI) for 
C36H52N6O10. Calculated mass of molecular ion 729.3818 [M+H]+. Measured mass: 
729.3818; IR νmax cm-1 3297, 3250-2750, 1655, 1508, 1438, 1365, 1230, 1162, 1018; 1H-
NMR (400 MHz; d6-DMSO) δH 9.59 (2H, broad, s, 2 x OH), 9.17 (2H, s, 2 x NH),  7.93-7.86 
(2H, m, 2 x NHCH2), 7.30-7.20 (4H, m, Ar-H), 6.98 (2H, d, J = 7.3 Hz, 2 x NHCH), 6.69 
(2H, d, J = 8.7 Hz, Ar-H), 4.06 (2H, p, J = 6.9 Hz, 2 x CH), 3.12-3.04 (4H, m, 2 x CH2NH), 
2.70 (4H, t, J = 7.8 Hz, 2 x CH2CH2CO), 2.31 (4H, t, J = 7.8 Hz, 2 x CH2CO), 1.38 (18H, s, 6 
x CH3), 1.18 (6H, d, J = 7.3 Hz, 2 x CH3); 13C-NMR (101 MHz; d6-DMSO) δC 172.4 (2 x 
C=O) 171.6 (2 x C=O), 155.6 (2 x C=O), 151.5 (2 x Ar-C), 131.2 (2 x Ar-C), 128.0 (2 x Ar-
C), 121.8 (2 x Ar-C), 119.0 (2 x Ar-C), 115.3 (2 x Ar-C), 78.5 (2 x C(CH3)3), 50.8 (2 x 
CHCH3), 38.9 (2 x CH2NH), 36.0 (2 x CH2), 28.7 (2 x C(CH3)3), 26.6 (2 x CH2), 18.8 (2 x 
CH3). 
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7.1.4.1.14. 1-Hydroxy-N-[2-[3-(5-amino-2-
hydroxyphenyl)propanamido]ethyl]naphthalene-2-carboxamide; Boc L-alanine 
derivative  36. Compound 36 was synthesized from the crude compound 35 (0.39 g, 1.00 
mmol), Boc-L-alanine (0.20 g, 1.05 mmol), N-methylmorpholine (0.10 g, 1.00 mmol) and 
IBCF (0.14 g, 1.00 mmol) in dry THF/DMF (20 mL, 2:1). The crude product was purified by 
column chromatography (eluent: CH2Cl2/EtOH 19:1) giving compound 36 (0.40 g, 72%) as a 
light pink powder, m.p. 114-115 °C. HRMS (NSI) for C30H36N4O7. Calculated mass of 
molecular ion 565.2657 [M+H]+. Measured mass: 565.2653; IR νmax cm-1 3350-3000, 2933, 
1640, 1597, 1538, 1503, 1254, 1160, 764; 1H-NMR (400 MHz; d6-DMSO) δH 9.59 (1H, s, 
NH), 9.18 (1H, broad, s, OH), 9.06-9.00 (1H, m, NHCH2), 8.26 (1H, d, J = 8.2 Hz, Ar-H), 
8.09 (1H, t, J = 5.5 Hz, NHCH2), 7.88-7.83 (2H, m, Ar-H), 7.64 (1H, t, J = 8.2 Hz, Ar-H), 
7.55 (1H, t, J = 8.2 Hz, Ar-H), 7.38 (1H, d, J = 9.2 Hz, Ar-H), 7.32-7.28 (1H, m, Ar-H), 7.22 
(1H, dd, J = 8.7 and 2.3 Hz, Ar-H), 6.97 (1H, d, J = 7.3 Hz, NHCH), 6.69 (1H, d, J = 8.7 Hz, 
Ar-H), 4.06 (1H, p, J = 6.9 Hz, CH), 3.48-3.25 (4H, m, 2 x CH2NH), 2.72 (2H, t, J = 7.3 Hz, 
CH2), 2.34 (2H, t, J = 7.3 Hz, CH2), 1.37 (9H, s, 3 x CH3), 1.18 (3H, d, J = 7.3 Hz, CH3); 13C-
NMR (101 MHz; d6-DMSO) δC 172.7 (C=O), 171.6 (C=O), 171.2 (C=O), 160.2 (C=O),  
155.6 (Ar-C), 151.5 (Ar-C), 136.3 (Ar-C), 131.2 (Ar-C), 129.3 (Ar-C), 128.0 (Ar-C), 126.3 
(2 x Ar-C), 125.3 (Ar-C), 123.5 (Ar-C), 123.2 (Ar-C), 121.8 (Ar-C), 119.0 (Ar-C), 118.1 (Ar-
C), 115.3 (Ar-C), 107.6 (Ar-C), 78.5 (C(CH3)3), 50.7 (CHCH3), 39.6 (CH2NH signal 
obscured by d6-DMSO signal, can be seen by DEPT), 38.5 (CH2NH), 36.1 (CH2), 28.7 
(C(CH3)3), 26.6 (CH2), 18.8 (CH3). 
7.1.5. Synthesis of amino acid hydrochlorides 8, 9, 31 and 37 and of the amine 
hydrochloride 33.          
7.1.5.1. General Procedure. The Boc-protected aminophenol 16, 17, 30, 32 or 36 was added 
to a saturated solution of dry HCl in ethyl acetate. The mixture was stirred at rt for 1-6 h. 
7.1.5.1.1. Ethyl 3-(5-Amino-2-hydroxyphenyl)propanoate; L-alanine derivative HCl salt 
8a. This substrate was prepared from compound 16a (0.20 g) and anhydrous EtOAc/HCl (10 
mL) for 4 hours. The solvent was evaporated yielding an oily residue which solidified 
overnight giving compound 8a (0.16 g, 96%) as a red, waxy material. HRMS (NSI) for 
C14H20N2O4. Calculated mass of molecular ion 281.1496 [M+H]+. Measured mass: 281.1498; 
IR νmax cm-1 3500-2500, 1673, 1501, 1204, 1100, 816; 1H-NMR (270 MHz; d6-DMSO) δH 
10.36 (1H, s, OH), 9.42 (1H, s, NH), 8.3 (3H, s, broad, NH3+), 7.33-7.26 (2H, m, Ar-H), 6.77 
(1H, d, J = 9.2 Hz, Ar-H), 4.09-3.94 (3H, m, CH2O, CH), 2.74 (2H, t, J = 6.8 Hz, 
CH2CH2CO), 2.55-2.46 (2H, m, CH2CO), 1.43 (3H, d, J = 7.2 Hz, CH3), 1.16 (3H, t, J = 7.1 
Hz, CH3); 13C-NMR (101 MHz; d6-DMSO) δC 172.9 (C=O), 167.9 (C=O), 152.2 (Ar-C), 
130.3 (Ar-C), 127.1 (Ar-C), 122.0 (Ar-C), 119.3 (Ar-C), 115.3 (Ar-C), 60.3 (CH2CH3), 49.3 
(CHCH3), 34.0 (CH2), 26.2 (CH2), 17.8 (CHCH3), 14.6 (CH2CH3).  
7.1.5.1.2. Ethyl 3-(5-Amino-3-bromo-2-hydroxyphenyl)propanoate; L-alanine derivative 
HCl salt 8b. This substrate was prepared from compound 16b (0.50 g) in anhydrous 
EtOAc/HCl (15 mL) for 3 h. The solvent was evaporated giving compound 8b (0.42 g, 
97.5%) as a brown wax. HRMS (NSI) for C14H19BrN2O4. Calculated mass of molecular ion 
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359.0601 [M+H]+. Measured mass: 359.0603; IR νmax cm-1 3600-2600, 1682, 1478, 1228, 
1160; 1H-NMR (400 MHz; d6-DMSO) δH 10.74 (1H, d, J = 15.11 Hz, NH), 8.93 (1H, s, 
broad, OH), 8.30 (3H, broad, s, NH3+), 7.72 (1H, t, J = 2.3 Hz, Ar-H), 7.24 (1H, t, J = 2.3 Hz, 
Ar-H), 4.02-3.92 (3H, m, CH2O, CH), 2.78-2.70 (2H, m, CH2CH2CO), 2.48-2.35 (2H, m, 
CH2CO), 1.36 (3H, d, J = 6.9 Hz, CH3) 1.08 (3H, t, J = 7.1 Hz, CH3).13C-NMR (101 MHz; 
d6-DMSO) δC 172.6 (C=O), 168.4 (C=O), 148.4 (Ar-C) 132.1 (Ar-C), 130.8 (Ar-C), 122.1 
(Ar-C), 121.0 (Ar-C), 111.7 (Ar-C), 60.4 (CH2CH3), 49.3 (CHNH3), 33.9 (CH2), 26.8 (CH2), 
17.7 (CH3), 14.6 (CH3). 
7.1.5.1.3. 3-(5-Amino-2-hydroxyphenyl)-N-(2H-1,3-benzodioxol-5-yl)propanamide; L-
alanine derivative HCl salt  8c. This substrate was prepared from compound 16c (0.20 g) in 
anhydrous EtOAc/HCl (15 mL) for 3 h. The resulting precipitate was collected and dried 
giving compound 8c (0.16 g, 92%) as an off white powder, m.p. 177-179 °C. HRMS (NSI) 
for C19H21N3O5. Calculated mass of molecular ion 372.1554 [M+H]+. Measured mass: 
372.1547; IR νmax cm-1 3295, 3280-2500, 1657, 1564, 1489, 1237, 1043, 797; 1H -NMR (400 
MHz; d6-DMSO) δH 10.42 (1H, s, NH), 9.97 (1H, s, NH), 9.43 (1H, broad, s, OH), 8.33 (3H, 
d, J = 3.7 Hz, NH3+), 7.38-7.26 (3H, m, Ar-H), 6.97(1H, dd, J = 8.7 and 2.1 Hz, Ar-H), 6.85-
6.76 (2H, m, Ar-H), 5.97 (2H, s, CH2O), 4.00 (1H, m, CH) 2.79 (2H, t, J = 7.6 Hz, 
CH2CH2CO), 2.54 (2H, m, CH2CO), 1.44 (3H, d, J = 6.9 Hz, CH3); 13C-NMR (68 MHz; d6-
DMSO) δC 170.9 (C=O), 168.0 (C=O), 152.3 (Ar-C), 147.5 (Ar-C), 143.1 (Ar-C), 134.4 (Ar-
C), 130.4 (Ar-C), 128.0 (Ar-C), 122.1 (Ar-C), 119.3 (Ar-C), 115.4 (Ar-C), 112.4 (Ar-C), 
108.5 (Ar-C), 102.0 (Ar-C), 101.4 (CH2O), 49.2 (CHCH3), 36.8 (CH2), 26.5 (CH2), 17.9 
(CHCH3).  
7.1.5.1.4. 3-(5-Amino-2-hydroxyphenyl)-N-(3,4-dimethoxyphenyl)propanamide; L-
alanine derivative HCl salt 8d.  This substrate was prepared from compound 16d (0.30 g) in 
anhydrous EtOAc/HCl (10 mL) for 4 h. The resulting precipitate was collected giving 
compound 8d (0.23 g, 81%) as a waxy, hydroscopic brown solid (0.23 g, 81%). HRMS (NSI) 
for C20H25N3O5. Calculated mass of molecular ion 388.1867 [M+H]+. Measured mass: 
388.1860; IR νmax cm-1 3500-2750, 2750-2400, 1509, 1233, 1138, 1118; 1H-NMR (400 MHz; 
d6-DMSO) δH 10.47 (1H, s, NH), 10.28 (1H, s, broad, OH), 9.44 (1H, s, NH),  8.37 (3H, s, 
broad, NH3+), 7.34-7.29 (2H, m, Ar-H), 7.05-6.99 (2H, m, Ar-H), 6.94 (1H, dd, J = 8.7 and 
2.3 Hz, Ar-H), 6.88-6.77 (1H, m, Ar-H), 4.02 (1H, m, CH), 3.77 (2 x 3H, d, J = 2.3 Hz, 2 x 
CH3), 2.72 (2H, t, J = 7.6 Hz, CH2), 2.47 (2H, t, J = 7.6 Hz, CH2) 1.45 (3H, t, J = 6.9 Hz, 
CH3); 13C-NMR (101 MHz; d6-DMSO) δC 174.5 (C=O), 167.9 (C=O), 152.2 (Ar-C), 149.6 
(Ar-C), 148.7 (Ar-C), 130.3 (Ar-C), 127.5 (Ar-C), 125.0 (Ar-C), 121.9 (Ar-C), 119.3 (Ar-C), 
115.6 (Ar-C), 115.4 (Ar-C), 112.6 (Ar-C), 107.6 (Ar-C), 56.3 (CH3O), 56.2 (CH3O), 59.3 
(CHCH3), 34.0 (CH2), 26.2 (CH2), 17.8 (CHCH3).  
7.1.5.1.5. 3-(5-Amino-2-hydroxyphenyl)-N-(4-hydroxyphenyl)propanamide; L-alanine 
derivative HCl salt 8f. This substrate was prepared from compound 16f (0.40 g) in 
anhydrous EtOAc/HCl (10 mL) for 1 h. The resulting precipitate was collected and dried in a 
desiccator under vacuum giving compound 8f (0.33 g, 96%) as an off white powder, m.p. 
171-173 °C. HRMS (NSI) for C18H21N3O4. Calculated mass of molecular ion 344.1605 
[M+H]+. Measured mass: 344.1605; IR νmax cm-1 3550-2450, 1656, 1508, 1217, 1105, 826; 
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1H-NMR (270 MHz; d6-DMSO) δH 10.38 (1H, s, NH), 9.70 (1H, s, NH), 8.28 (3H, m, NH3+), 
7.35-7.28 (3H, m, Ar-H), 7.24 (1H, dd, J = 8.7 and 2.3 Hz, Ar-H), 6.74 (1H, d, J = 8.7 Hz, 
Ar-H), 6.63 (2H, d, J = 8.7 Hz, Ar-H), 4.20 (1H, s, broad, OH), 3.95 (1H, m, CH), 2.73 (2H, 
t, J = 7.6 Hz, CH2), 2.45 (2H, m, CH2), 1.39 (3H, d, J = 6.9 Hz, CH3); 13C-NMR (101 MHz; 
d6-DMSO) δC 170.5 (C=O), 167.7 (C=O), 153.7 (Ar-C), 152.3 (Ar-C), 131.5 (Ar-C), 130.3 
(Ar-C), 128.1 (Ar-C), 122.1 (Ar-C), 121.4 (2 x Ar-C), 119.3 (Ar-C), 115.5 (2 x Ar-C), 115.4 
(Ar-C), 49.3 (CHCH3), 36.6 (CH2), 26.5 (CH2), 17.8 (CHCH3). 
7.1.5.1.6. (S)-Methyl 2-[3-(5-Amino-2-hydroxyphenyl)propanamido]-2-phenyl-2-
carboxylate; L-alanine derivative HCl salt 8g. This substrate was prepared from compound 
16g (0.20 g) in anhydrous EtOAc/HCl (15 mL) for 4 h. The solvent was evaporated giving 
compound 8g (0.17 g, 97%) as an oily product which solidified overnight affording red solid, 
m.p. 71-74 °C. HRMS (NSI) for C21H25N3O5. Calculated mass of molecular ion 400.1867 
[M+H]+. Measured mass: 400.1860; IR νmax cm-1 3550-2450, 1737, 1673, 1497, 1213, 1101, 
697; 1H-NMR (270 MHz; d6-DMSO) δH 10.47 (1H, s, NH), 9.41 (1H, broad, s, OH),  8.77 
(1H, d, J = 6.9 Hz, NH), 8.37 (3H, d, J = 3.2 Hz, NH3+), 7.43-7.28 (7H, m, Ar-H), 6.78 (1H, 
d, J = 9.2 Hz, Ar-H), 5.42 (1H, d, J = 6.9 Hz, CH), 4.08 (1H, m, CH), 3.62 (3H, s, CH3), 2.71 
(2H, m, CH2CH2CO), 2.44 (2H, t, J = 7.2 Hz, CH2CO), 1.45 (3H, d, J = 6.9 Hz, CH3); 13C-
NMR (68 MHz; d6-DMSO) δC 172.5 (C=O), 171.8 (C=O), 167.9 (C=O), 152.3 (Ar-C), 136.8 
(Ar-C), 130.4 (Ar-C), 129.2 (2 x Ar-C), 128.8 (Ar-C), 128.6 (2 x Ar-C), 128.0 (Ar-C), 122.1 
(Ar-C), 119.3 (Ar-C), 115.4 (Ar-C), 56.8 (CHNH), 52.8 (CH3), 49.3 (CHCH3), 35.3 (CH2), 
26.6 (CH2), 18.9 (CHCH3). 
7.1.5.1.7. 3-(5-Amino-2-hydroxyphenyl)-N-(4-pyridylmethyl)propanamide; L-alanine 
derivative HCl salt 8h. This substrate was prepared by dissolving compound 16h (0.20 g) in 
EtOAc (3 mL) and then adding anhydrous EtOAc/HCl (5 mL) with stirring. The resulting 
precipitate was collected and dried in a desiccator under vacuum giving compound 8h (0.16 
g, 93%) as a grey powder, m.p. 183-184 °C. HRMS (NSI) for C18H22N4O3. Calculated mass 
of molecular ion 343.1765 [M+H]+. Measured mass: 343.1765; IR νmax cm-1 3550-2500, 
1639, 1503, 1232, 1105, 775; 1H-NMR (400 MHz; d6-DMSO) δH 10.58 (1H, s, NH), 9.49 
(1H, broad s , OH), 8.85 (1H, t, J = 5.6 Hz, NHCH2), 8.81 (2H, d, J = 6.9 Hz, Ar-H), 8.41 
(3H, d, J = 2.9 Hz, NH3+), 7.76 (2H, d, J = 6.9 Hz, Ar-H), 7.36-7.30 (2H, m, Ar-H), 6.83 (1H, 
d, J = 8.7 Hz, Ar-H), 4.52 (2H, d, J = 6.0 Hz, CH2NH), 4.07-4.00 (1H, m, CHNH3+), 2.78 
(2H, t, J = 7.6.0 Hz, CH2), 2.54-2.48 (2H, m, CH2), 1.45 (3H, d, J = 7.3 Hz, CHCH3); 13C-
NMR (101 MHz; d6-DMSO) δC 173.0 (C=O), 167.9 (C=O), 160.8 (Ar-C), 152.3 (Ar-C), 
141.8 (2 x Ar-C), 130.3 (Ar-C), 127.7 (Ar-C), 125.1 (2 x Ar-C), 122.2 (Ar-C), 119.3 (Ar-C), 
115.4 (Ar-C) 49.2 (CHCH3), 42.2 (CH2NH), 35.5 (CH2), 26.7 (CH2), 17.8 (CH3).  
7.1.5.1.8. 3-(5-Amino-2-hydroxyphenyl)-N-(3-imidazol-1-ylpropyl)propanamide; L-
alanine derivative HCl salt 8i. This substrate was prepared by dissolving compound 16i 
(0.20 g) in methanol (4 mL) and then adding anhydrous EtOAc/HCl (6 mL) to the solution. 
The mixture was stirred for 1 h and then filtered. The filtrate was evaporated giving 
compound 8i (0.14 g, 81%) as a red wax. LRMS (ES) for C18H25N5O3. Calculated mass of 
molecular ion 360.42 [M+H]+. Measured mass: 360.43; IR νmax cm-1 3600-2550, 1608, 1440, 
1260, 1085, 797; 1H-NMR (400 MHz; d6-DMSO) δH 10.56 (1H, broad, s, OH), 9.22 (1H, s, 
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Ar-H), 8.45-8.30 (4H, m, NH3+, NH), 8.19 (1H, t, J = 5.73 Hz, NHCH2), 7.83-7.81 (1H, m, 
Ar-H), 7.73-7.70 (1H, m, Ar-H), 7.34-7.28 (2H, m, Ar-H), 6.79 (1H, d, J = 8.7 Hz, Ar-H), 
4.16 (2H, t, J = 6.7 Hz, CH2CH2CH2NH),  4.07-3.99 (1H, m, CH), 3.02 (2H, q, J = 6.0 Hz, 
CH2CH2CH2NH), 2.72 (2H, t, J = 7.8 Hz, CH2), 2.35 (2H, t, J = 7.8 Hz, CH2), 1.92 (2H, p, J 
= 6.4 Hz, CH2CH2CH2NH) 1.44 (3H, d, J = 6.9 Hz, CH3); 13C-NMR (101 MHz; d6-DMSO) 
δC 172.5 (C=O), 167.9 (C=O), 152.2 (Ar-C), 135.9 (Ar-C), 130.4 (Ar-C), 128.0 (Ar-C), 122.5 
(Ar-C), 122.0 (Ar-C), 120.3 (Ar-C), 119.2 (Ar-C), 115.4 (Ar-C), 49.2 (CHCH3), 46.7 (CH2), 
35.8 (CH2), 35.5 (CH2), 30.2 (CH2), 26.6 (CH2), 17.8 (CH3). 
7.1.5.1.9. Ethyl 3-(5-Amino-2-hydroxyphenyl)propanoate; β-alanine derivative HCl salt 
9a. This substrate was prepared from compound 17a (0.20 g) in anhydrous EtOAc/HCl (15 
mL) for 3 h. The solvent was evaporated to giving compound 9a (0.16 g, 96%) as a brown 
wax. HRMS (NSI) for C14H20N2O4. Calculated mass of molecular ion 281.1496 [M+H]+. 
Measured mass: 281.1488; IR νmax cm-1 3600-2500, 1719, 1660, 1556, 1504s, 1223, 1184, 
823; 1H-NMR (400 MHz; d6-DMSO) δH 9.97 (1H, s, NH), 9.31 (1H, s, broad, OH), 7.98 (3H, 
s, broad, NH3+), 7.32-7.20 (2H, m, Ar-H), 6.73 (1H, d, J = 8.7 Hz, Ar-H), 4.03 (2H, q, J = 7.1 
Hz, CH2CH3) 3.04 (2H, m, CH2NH3+), 2.69 (4H, m, CH2CH2CO, CH2CH2NH3+), 2.44 (2H, t, 
J = 7.3 Hz , CH2CO), 1.16 (3H, t, J = 7.3 Hz, CH3); 13C-NMR (101 MHz; d6-DMSO) δC 
174.5 (C=O), 168.0 (C=O), 151.7 (Ar-C), 131.0 (Ar-C), 127.2 (Ar-C), 121.8 (Ar-C), 119.2 
(Ar-C), 115.2 (Ar-C), 60.3 (CH2CH3), 35.6 (CH2), 34.1 (CH2), 33.4 (CH2), 26.2 (CH2), 14.6 
(CH3). 
7.1.5.1.10. Ethyl 3-(5-Amino-3-bromo-2-hydroxyphenyl)propanoate; β-alanine 
derivative HCl salt 9b. This substrate was prepared from compound 17b (0.50 g) in 
anhydrous EtOAc/HCl (15 mL) for 3 h. The solvent was evaporated giving compound 9b 
(0.43 g, 99%) as a brown solid, m.p. 63-64 °C. HRMS (NSI) for C14H19BrN2O4. Calculated 
mass of molecular ion 359.0601 [M+H]+. Measured mass: 359.0606; IR νmax cm-1 3350, 
3314, 1707, 1640, 1585, 1470, 1440, 1245, 1171, 1096, 850; 1H-NMR (400 MHz; d6-DMSO) 
δH 10.2 (1H, s, NH), 8.84 (1H, s, broad, OH), 7.97 (3H, s, broad, NH3+), 7.73 (1H, d, J = 2.3 
Hz, Ar-H), 7.20 (1H, d, J = 2.3 Hz, Ar-H), 3.98 (2H, q, J = 7.1 Hz, CH2CH3), 2.96 (2H, m, 
CH2NH3+), 2.76 (2H, t, J = 7.6 Hz, CH2CH2CO), 2.65 (2H, t, J = 6.6 Hz, CH2CH2NH3+) 2.49 
(2H, m, CH2CO), 1.10 (3H, t, J = 7.1 Hz, CH3); 13C-NMR (101 MHz; d6-DMSO) δC 172.7 
(C=O), 168.5 (C=O), 147.9 (Ar-C), 132.8 (Ar-C), 130.6 (Ar-C), 122.0 (Ar-C), 120.8 (Ar-C), 
111.7 (Ar-C), 60.4 (CH2CH3), 35.4 (CH2), 33.9 (CH2), 33.6 (CH2), 26.8 (CH2), 14.6 (CH3). 
7.1.5.1.11. 3-(5-Amino-2-hydroxyphenyl)-N-(2H-1,3-benzodioxol-5-yl)propanamide; β-
alanine derivative HCl salt 9c. This substrate was prepared from compound 17c (0.30 g) in 
anhydrous EtOAc/HCl (15 mL) for 3 h. The solvent was evaporated giving compound 9c 
(0.25 g, 96%) as a brown powder, m.p. 155 °C. HRMS (NSI) for C19H21N3O5. Calculated 
mass of molecular ion 372.1554 [M+H]+. Measured mass: 372.1556; IR νmax cm-1 3600-2500, 
1653, 1557, 1490, 1229, 1034, 797; 1H-NMR (400 MHz; d6-DMSO) δH 9.98 (1H, s, NH), 
9.94 (1H, s, NH), 9.30 (1H, broad, s, OH), 8.01 (3H, broad, s, NH3+), 7.34 (2H, t, J = 1.8 Hz, 
Ar-H), 7.25 (1H, dd, J = 8.7 and 2.8 Hz, Ar-H), 6.97 (1H, dd, J = 8.2 and 1.8 Hz, Ar-H), 6.83 
(1H, d, J = 8.2 Hz, Ar-H), 6.75 (1H, d, J = 8.7 Hz, Ar-H), 5.97 (2H, s, CH2O), 3.04 (2H, 
sextet, J = 6.4 Hz, CH2NH3+), 2.76 (2H, m, CH2CH2CO), 2.68 (2H, t, J = 6.9 Hz, 
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CH2CH2NH3+), 2.52 (2H, m, CH2CO); 13C-NMR (101 MHz; d6-DMSO) δC 170.9 (C=O), 
168.0 (C=O), 151.8 (Ar-C), 147.4 (Ar-C), 143.1 (Ar-C), 134.3 (Ar-C), 131.0 (Ar-C), 127.7 
(Ar-C), 122.0 (Ar-C), 119.1 (Ar-C), 115.2 (Ar-C), 112.4 (Ar-C), 108.5 (Ar-C), 101.9 (Ar-C), 
101.4 (CH2O), 36.7 (CH2), 35.6 (CH2), 33.4 (CH2), 26.5 (CH2).  
7.1.5.1.12. 3-(5-Amino-2-hydroxyphenyl)-N-[4-[3-(5-amino-2-
hydroxyphenyl)propanamido]phenyl]propanamide; bis-L-alanine derivative bis-HCl 
salt 31a. This substrate was prepared from compound 30a (0.50 g) in anhydrous EtOAc/HCl 
(15 mL) for 3 h. The resulting precipitate was collected and dried giving compound 31a (0.40 
g, 96%) as a brick-red powder, m.p. 206-207 °C. HRMS (NSI) for C30H36N6O6. Calculated 
mass of molecular ion 577.2769 [M+H]+. Measured mass: 577.2766; IR νmax cm-1 3600-2600, 
1658, 1565, 1495, 1240, 830; 1H-NMR (400 MHz; d6-DMSO) δH 10.42 (2H, s, 2 x NH), 9.95 
(2H, s, 2 x NH),  9.40 (2H, broad, s, 2 x OH), 8.31 (6H, broad, s, 2 x NH3+), 7.46 (4H, s, Ar-
H), 7.31 (2H, d, J = 2.3 Hz, Ar-H), 7.26 (2H, dd, J = 8.7 and 2.8 Hz, Ar-H), 6.75 (2H, d, J =  
8.7 Hz, Ar-H), 4.03 (2H, m, 2 x CH), 2.75 (4H, t, J = 7.3 Hz, 2 x CH2CH2CO), 2.51 (4H, t, J 
= 7.6 Hz, 2 x CH2CO), 1.40 (6H, d, J = 6.9 Hz, 2 x CH3); 13C-NMR (101 MHz; d6-DMSO) 
δC 170.9 (2 x C=O), 167.9 (2 x C=O), 152.3 (2 x Ar-C), 135.1 (2 x Ar-C), 130.3 (2 x Ar-C), 
128.0 (2 x Ar-C), 122.1 (2 x Ar-C), 120.0 (4 x Ar-C), 119.3 (2 x Ar-C), 115.4 (2 x Ar-C), 
49.3 (2 x CHCH3), 36.7 (2 x CH2), 26.5 (2 x CH2), 17.7 (2 x CH3). 
7.1.5.1.13. 3-(5-Amino-2-hydroxyphenyl)-N-[2-[3-(5-amino-2-
hydroxyphenyl)propanamido]ethyl]propanamide; bis-L-alanine derivative bis-HCl salt 
31b. This substrate was prepared from compound 30b (0.30 g) in anhydrous EtOAc/HCl (15 
mL) for 3 h. The resulting precipitate was collected and dried giving compound 31b (0.24 g, 
97%) as a pink powder, m.p. 70-71 °C; HRMS (NSI) for C26H36N6O6. Calculated mass of 
molecular ion 529.2769 [M+H]+. Measured mass: 529.2762; IR νmax cm-1 3600-2400, 1673, 
1601, 1557, 1501, 1237, 1103, 819; 1H-NMR (400 MHz; d6-DMSO) δH 10.44 (2H, s, 2 x 
NH),  9.35 (2H, broad, s, 2 x OH), 8.31 (6H, s, 2 x NH3+), 7.98-7.93 (2H, m, 2 x NHCH2), 
7.29-7.24 (4H, m, Ar-H), 6.73 (2H, d, J = 8.7 Hz, Ar-H), 4.03-3.97 (2H, m, 2 x CH), 3.06-
3.01 (4H, m, 2 x CH2NH), 2.66 (4H, t, J = 7.6 Hz, 2 x CH2CH2CO), 2.27 (4H, t, J = 7.8 Hz, 2 
x CH2CO), 1.40 (6H, d, J = 6.9 Hz, 2 x CH3); 13C-NMR (101 MHz; d6-DMSO) δC 172.4 (2 x 
C=O) 167.9 (2 x C=O), 152.2 (2 x Ar-C), 130.4 (2 x Ar-C), 128.1 (2 x Ar-C), 121.9 (2 x Ar-
C), 119.2 (2 x Ar-C), 115.4 (2 x Ar-C), 49.3 (2 x CHCH3), 38.9 (2 x CH2NH), 35.9 (2 x 
CH2), 26.5 (2 x CH2), 17.8 (2 x CH3). 
7.1.5.1.14. N-(2-Aminoethyl)-3-(2-hydroxy-5-nitrophenyl)propanamide hydrochloride 
33. Compound 32 (1.00 g, 2.83 mmol) was stirred in anhydrous EtOAc/HCl (20 mL) for 3 h. 
The resulting precipitate was collected and dried giving compound 33 (0.81 g, 99%) as a pale 
yellow solid, m.p. ˃260 °C. HRMS (NSI) for C11H15N3O4. Calculated mass of molecular ion 
254.1135 [M+H]+. Measured mass: 254.1142; IR νmax cm-1 3390, 3300-2500, 1644, 1582, 
1547, 1488, 1325, 1276, 1264, 1082; 1H-NMR (400 MHz; d6-DMSO) δH 11.29 (1H, broad, s, 
OH), 8.20 (1H, t, J = 5.5 Hz, NH), 8.02 (3H, broad, s, NH3+), 7.95-7.91 (2H, m, Ar-H), 7.01 
(1H, d, J = 9.6 Hz, Ar-H), 3.24 (2H, q, J = 6.2 Hz, CH2NH), 2.82-2.71 (4H, m, CH2NH3+, 
CH2CH2CO), 2.38 (2H, t, J = 7.8 Hz, CH2CO); 13C-NMR (101 MHz; d6-DMSO) δC 172.6 
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(C=O), 162.6 (Ar-C), 139.8 (Ar-C), 129.2 (Ar-C), 126.0 (Ar-C), 124.4 (Ar-C), 115.6 (Ar-C), 
39.0 (CH2), 36.9 (CH2), 34.9 (CH2), 25.8 (CH2). 
7.1.5.1.15. 1-Hydroxy-N-[2-[3-(5-amino-2-
hydroxyphenyl)propanamido]ethyl]naphthalene-2-carboxamide; L-alanine derivative 
HCl salt 37. Compound 36 (0.15 g) was stirred in anhydrous EtOAc/HCl (10 mL) for 3 h. 
The solvent was then evaporated and the crude product was purified by column 
chromatography (eluent: CH2Cl2 changing to MeOH).  The methanol fraction was evaporated 
giving compound 37 (0.04 g, 30%) as a brown, hydroscopic solid. HRMS (NSI) for 
C25H28N4O5. Calculated mass of molecular ion 465.2132 [M+H]+. Measured mass: 465.2129; 
IR νmax cm-1 3224, 3310, 3100-2500, 1637, 1597, 1540, 1501, 1275, 1258, 1104, 764; 1H-
NMR (400 MHz; d6-DMSO) δH 10.42 (1H, s, NH), 9.40 (1H, broad, s, OH), 9.17 (1H, t, J = 
5.3 Hz,  NHCH2), 8.36-8.30 (3H, s, broad, NH3+), 8.27 (1H, d, J = 8.3 Hz, Ar-H), 8.19 (1H, t, 
J = 5.7 Hz, NHCH2), 7.93 (1H, d, J = 8.7 Hz, Ar-H), 8.24 (1H, d, J = 8.2 Hz, Ar-H), 7.74-
7.62 (2H, m, Ar-H), 7.55 (1H, t, J = 7.3 Hz, Ar-H), 7.38 (1H, d, J = 9.2 Hz, Ar-H), 7.31-7.28 
(1H, m, Ar-H), 6.78 (1H, d, J = 8.7 Hz, Ar-H), 4.05-3.94 (1H, m, CHCH3), 3.51-3.38 (2H, m, 
CH2NH), 3.30 (2H, q, J = 6.0 Hz, CH2NH) 2.74 (2H, t, J = 7.8 Hz, CH2), 2.36 (2H, t, J = 7.8 
Hz, CH2), 1.44 (3H, d, J = 6.9 Hz, CHCH3); 13C-NMR (101 MHz; d6-DMSO) δC 172.6 
(C=O), 171.2 (C=O), 160.1 (C=O), 152.2 (Ar-C), 136.3 (Ar-C), 132.1 (Ar-C), 130.3 (Ar-C), 
129.3 (Ar-C), 129.2 (Ar-C), 128.0 (Ar-C), 126.3 (Ar-C), 125.2 (Ar-C), 123.5 (Ar-C), 123.3 
(Ar-C), 122.0 (Ar-C), 119.3 (Ar-C), 118.1 (Ar-C), 115.4 (Ar-C), 107.6 (Ar-C), 49.3 
(CHCH3), 39.6 (CH2NH, signal obscured by d6-DMSO signal, can be seen by DEPT), 38.6 
(CH2NH), 35.9 (CH2), 26.6 (CH2), 17.8 (CH3). 
7.1.6. Synthesis of pyroglutamic acid derivatives 10. 
7.1.6.1. General procedure. Compounds 10 were prepared following the general procedure 
described in Section 6.1.4.1. using L-pyroglutamic acid as the amino acid. 
7.1.6.1.1. Ethyl 3-(5-Amino-2-hydroxyphenyl)propanoate; L-pyroglutamic acid 
derivative 10a. This substrate was synthesized from compound 11a (0.21 g, 1.00 mmol), L-
pyroglutamic acid (0.13 g, 1.05 mmol), N-methylmorpholine (0.10 g, 1.00 mmol) and IBCF 
(0.14 g, 1.00 mmol) in dry THF/DMF (14 mL, 3:1). Yield: (0.27 g, 84%) as a brown powder, 
m.p. 91-92 °C. HRMS (NSI) for C16H20N2O5. Calculated mass of molecular ion 321.1445 
[M+H]+. Measured mass: 321.1444; IR νmax cm-1 3283, 3216, 2962, 1722, 1659, 1549, 1436, 
1223, 1175, 813, 710; 1H-NMR (400 MHz; d6-DMSO) δH 9.80 (1H, s, NH), 9.31 (1H, s, 
broad, OH), 7.89 (1H, s, NH), 7.31-7.26 (2H, m, Ar-H), 6.72 (1H, d, J = 8.7 Hz, Ar-H), 4.14 
(1H, m, CH) 4.04 (2H, q, J = 7.0 Hz, CH2CH3), 2.73 (2H, t, J = 7.8 Hz, CH2CH2CO), 2.52 
(2H, m, CH2CO), 2.34-2.24 (1H, m, γ-CH), 2.22-2.07 (2H, m, β-CH2), 1.99-1.91 (1H, m, γ-
CH), 1.16 (3H, t, J = 7.1 Hz, CH3); 13C-NMR (101MHz; d6-DMSO) δC 178.0 (C=O), 172.9 
(C=O), 171.0 (C=O), 151.8 (Ar-C), 130.9 (Ar-C), 127.0 (Ar-C), 121.1 (Ar-C), 119.4 (Ar-C), 
115.2 (Ar-C), 60.3 (CH2CH3), 56.8 (CHNH), 34.0 (CH2), 29.8 (CH2), 26.2 (CH2), 25.9 
(CH2), 14.6 (CH3).  
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7.1.6.1.2. Ethyl 3-(5-Amino-3-bromo-2-hydroxyphenyl)propanoate; L-pyroglutamic acid 
derivative 10b. Compound 10b was synthesized from compound 11b (0.58 g, 2.00 mmol), 
L-pyroglutamic acid (0.27 g, 2.10 mmol), N-methylmorpholine (0.20 g, 2.00 mmol) and 
IBCF (0.28 g, 2.00 mmol) in dry THF/DMF (20 mL, 3:1). Yield: (0.36 g, 45%) as a brown 
powder, m.p. 128 °C; HRMS (NSI) for C16H19BrN2O5. Calculated mass of molecular ion 
399.0550 [M+H]+. Measured mass: 399.0558; IR νmax cm-1 3413, 3281, 2944, 1671, 1588, 
1478, 1265, 1154, 1036; 1H-NMR (400 MHz; d6-DMSO) δH 10.08 (1H, s, NH), 8.91 (1H, s, 
OH), 7.93 (1H, m, NH), 7.74 (1H, s, Ar-H), 7.24 (1H, s, Ar-H), 4.23 (1H, q, J = 4.6 Hz, CH), 
4.05 (2H, q, J = 6.9 Hz, CH2CH3), 2.86 (2H, t, J = 7.3 Hz, CH2), 2.57 (2H, m, CH2), 2.48-
2.39 (1H, m, γ-CH), 2.34-2.22 (2H, m, β-CH2), 2.03-1.96 (1H, m, γ-CH), 1.15 (3H, t, J = 
7.33 Hz, CH3); 13C-NMR (101MHz; d6-DMSO) δC 178.0 (C=O), 172.7 (C=O), 171.5 (C=O), 
148.1 (Ar-C), 132.6 (Ar-C), 130.6 (Ar-C), 122.1 (Ar-C), 121.1 (Ar-C), 111.6 (Ar-C), 60.4 
(CH2CH3), 56.8 (CHNH), 33.9 (CH2), 29.7 (CH2), 26.8 (CH2), 25.8 (CH2), 14.6 (CH3).  
7.1.6.1.3. 3-(5-Amino-2-hydroxyphenyl)-N-(2H-1,3-benzodioxol-5-yl)propanamide; L-
pyroglutamic acid derivative 10c. This substrate was synthesized from compound 11c (0.30 
g, 1.00 mmol), L-pyroglutamic acid (0.13 g, 1.05 mmol), N-methylmorpholine (0.10 g, 1.00 
mmol) and IBCF (0.14 g, 1.00 mmol) in dry THF/DMF (14 mL, 3:1). Yield: (0.39 g, 95%) as 
a white powder, m.p. 229-231°C. HRMS (NSI) for C21H21N3O6. Calculated mass of 
molecular ion 412.1503 [M+H]+. Measured mass: 412.1500; IR νmax cm-1 3280, 3200-2600, 
1652, 1548, 1493, 1227, 1042, 798, 743, 694; 1H-NMR (400 MHz; d6-DMSO) δH 9.84 (1H, 
s, NH), 9.78 (1H, s, NH), 9.28 (1H, broad, s, OH), 7.88 (1H, s, NH), 7.32 (2H, dd, J = 10.5 
and 2.3 Hz, Ar-H), 7.27(1H, dd, J = 8.7 and 2.8 Hz, Ar-H), 6.94 (1H, dd, J = 8.7 and 1.8 Hz, 
Ar-H), 6.83 (1H, d, J = 8.7 Hz, Ar-H),  6.73 (1H, d, J = 8.7 Hz, Ar-H), 5.97 (2H, s, CH2O), 
4.13 (1H, m, CH), 2.78 (2H, t, J = 7.8 Hz, CH2CH2CO), 2.52 (2H, m, CH2CO), 2.34-2.25 
(1H, m, γ-CH), 2.22-2.07 (2H, m, β-CH2), 1.99-1.90 (1H, m, γ-CH); 13C-NMR (101MHz; d6-
DMSO) δC 178.0 (C=O), 171.0 (C=O), 170.8 (C=O), 151.8 (Ar-C), 147.5 (Ar-C), 143.2 (Ar-
C), 134.2 (Ar-C), 130.9 (Ar-C), 122.1 (Ar-C), 119.3 (Ar-C), 115.2 (Ar-C), 112.4 (Ar-C), 
112.4 (Ar-C), 108.5 (Ar-C), 101.9 (Ar-C), 101.4 (CH2O), 56.8 (CHNH), 36.7 (CH2), 29.8 
(CH2), 26.4 (CH2), 25.9 (CH2).  
7.1.7. Synthesis of 1-Naphthol derivatives 18-24. 
7.1.7.1. 2-Benzylnaphthalen-1-ol 18. To a stirred solution of compound 2518 (1.0 g, 4.27 
mmol) in ethanol (50 mL) was added rhodium(III) chloride hydrate (100 mg, 0.47 mmol). 
The mixture was heated at reflux for 24 h and then evaporated. Ethyl acetate  (40 mL) was 
added to the residue and the resulting mixture was washed with water (40 mL). The organic 
layer was separated, dried (MgSO4) and evaporated. The crude product was purified by 
column chromatography (eluent: ether/petroleum ether, b.p. 60-80 oC 1:9) giving compound 
18 (0.90 g, 90%) as grey crystals, m.p. 73 °C, lit. m.p. 73-74 °C.19 1H-NMR (400 MHz; d6-
DMSO) δH 9.25 (1H, s, OH), 8.18 (1H, d. J = 7.3 Hz, Ar-H), 7.74 (1H, dd, J = 7.2 and 2.1 
Hz, Ar-H), 7.43-7.36 (2H, m, Ar-H), 7.31 (1H, d, J = 8.2 Hz, Ar-H), 7.24-7.18 (5H, m, Ar-
H), 7.14-7.08 (1H, m, Ar-H), 4.10 (2H, s, CH2); 13C-NMR (101 MHz; d6-DMSO) δC 149.9 
(Ar-C), 141.9 (Ar-C), 133.7 (Ar-C), 129.5 (Ar-C), 129.1 (2 x Ar-C), 128.8 (2 x Ar-C), 128.0 
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(Ar-C), 126.2 (Ar-C), 125.9 (Ar-C), 125.9 (Ar-C), 125.4 (Ar-C), 122.5 (2 x Ar-C), 119.9 (Ar-
C), 35.8 (CH2).  
7.1.7.2. 8-Hydroxy-N-(pyridine-4-ylmethyl)naphthalene-1-carboxamide 19. To a stirred 
solution of phenyl 1-hydroxy-2-naphthoate (0.53 g, 2.0 mmol) in THF (25 mL) was added 4-
picolylamine (0.22 g, 2.0 mmol). The mixture was stirred at reflux for 24 h and then 
evaporated. The crude product was purified by column chromatography (eluent: CH2Cl2 then 
CH2Cl2/MeOH 7:3) giving compound 19 (0.42 g, 75%) as an orange solid, m.p. 132-134 °C. 
HRMS (NSI) for C17H14N2O2. Calculated mass of molecular ion 279.1128 [M+H]+. 
Measured mass: 279.1132; IR νmax cm-1 3244; 3044; 1622, 1597; 1548, 1401, 1332, 1272, 
999, 790, 764; 1H-NMR (400 MHz; d6-DMSO) δH 9.82 (1H, s, broad, NH), 8.56 (2H, d, J = 
6.0 Hz, Ar-H), 8.32 (1H, d, J = 8.2 Hz, Ar-H), 8.01 (1H, d, J = 8.7 Hz, Ar-H), 7.90 (1H, d, J 
= 7.8 Hz, Ar-H), 7.66 (1H, t, J = 7.6 Hz, Ar-H), 7.57 (1H, t, J = 7.1 Hz, Ar-H), 7.46-7.36 
(3H, m, Ar-H), 4.64 (2H, d, J = 5.0 Hz, CH2NH); 13C-NMR (101 MHz; d6-DMSO) δC 171.3 
(C=O), 160.6 (Ar-C), 150.2 (2 x Ar-C), 148.4 (Ar-C), 136.5 (Ar-C), 129.4 (Ar-C), 128.0 (Ar-
C), 126.23 (Ar-C), 125.5 (Ar-C), 123.7 (Ar-C), 123.3 (Ar-C), 122.7 (2 x Ar-C), 118.0 (Ar-C), 
107.5 (Ar-C), 42.1 (CH2).  
7.1.7.3. 8-Phenylsulphonyl-1-naphthol 20. The synthesis of this compound has been 
described in the literature.20 
7.1.7.4. Ethyl 8-Hydroxy-l-naphthoate 21. The synthesis of this compound has been 
described in the literature.21 
7.1.7.5. N-(2-Aminoethyl)-8-hydroxynaphthalene-1-carboxamide 22. To a stirred solution 
of ethylenediamine (1.41 g, 23.52 mmol) in THF (30 mL) at reflux was added a solution of 
compound 27 (1.00 g, 5.88 mmol) in THF (3 mL) dropwise. The mixture was kept at that 
temperature for 1 h after which time it was allowed to cool and then filtered. The resulting 
solid was washed with cold THF (20 mL) and then dried giving compound 22 (1.29 g, 95%) 
as a cream powder, m.p. 200-201 °C. HRMS (NSI) for C13H14N2O2. Calculated mass of 
molecular ion 231.1128 [M+H]+. Measured mass: 231.1127; IR νmax cm-1 3338, 3271, 3200-
2400, 1641, 1554, 1272, 1011, 825, 766; 1H-NMR (400 MHz; d6-DMSO) δH 8.20 (1H, s, 
broad, OH), 7.82 (1H, dd, J = 8.2 and 1.4 Hz,  Ar-H), 7.42-7.35 (1H, m, Ar-H), 7.32-7.26 
(2H, m, Ar-H), 7.23 (1H, dd, J = 8.2 Hz, J = 1.4 Hz, Ar-H), 6.80 (1H, dd, J = 6.9 and 1.8 Hz, 
Ar-H) 4.90 (2H, s, broad, NH2), 3.31 (2H, t, J = 6.0 Hz, CH2), 2.76 (2H, t, J = 6.2 Hz, CH2); 
13C-NMR (101 MHz; d6-DMSO) δC 172.5 (C=O), 155.7 (Ar-C), 135.8 (Ar-C), 135.1 (Ar-C), 
129.2 (Ar-C), 127.6 (Ar-C), 125.3 (Ar-C), 124.6 (Ar-C), 122.0 (Ar-C), 117.9 (Ar-C), 110.8 
(Ar-C), 42.5 (CH2), 41.5 (CH2).  
7.1.7.6. 8-Hydroxy-N-(2-phenylethyl)naphthalene-1-carboxamide 23. To a stirred solution 
of compound 2722 (0.50 g, 2.94 mmol) in THF (30 mL) was added 2-phenylethylamine (0.36 
g, 2.94 mmol). The mixture was stirred at reflux for 3 h and then evaporated. The crude 
product was dissolved in CH2Cl2 (20 mL) and filtered through silica (5 g). The silica was 
washed with CH2Cl2 (10 mL) and the combined organic filtrates were evaporated giving 
compound 23 (0.81 g, 95%) as a light yellow powder, m.p. 113-114 °C. HRMS (NSI) for 
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C19H17NO2. Calculated mass of molecular ion 292.1332 [M+H]+. Measured mass: 292.1332; 
IR νmax cm-1 3335, 3300-2700, 1621, 1538, 1261, 822, 764, 698; 1H-NMR (400 MHz; d6-
DMSO) δH 10.25 (1H, s, broad, OH), 8.41 (1H, t, J = 5.0 Hz, NH), 7.87 (1H, d, J = 7.3 Hz, 
Ar-H), 7.45-7.20 (9H, m, Ar-H), 6.89 (1H, dd, J = 7.3 and 1.4 Hz, Ar-H), 3.49 (2H, q, J = 7.3 
Hz, CH2NH) 2.89 (2H, t, J = 7.8 Hz, CH2CH2NH); 13C-NMR (101 MHz; d6-DMSO) δC 172.0 
(C=O), 153.9 (Ar-C), 140.3 (Ar-C), 135.7 (Ar-C), 134.7 (Ar-C), 129.5 (Ar-C), 129.2 (2 x Ar-
C), 128.9 (2 x Ar-C), 127.4 (Ar-C), 126.6 (Ar-C), 125.5 (Ar-C), 125.4 (Ar-C), 121.3 (Ar-C), 
119.5 (Ar-C), 110.9 (Ar-C), 41.6 (CH2), 35.4 (CH2).  
7.1.7.7. N-(2H-1,3-Benzodioxol-5-yl)-8-hydroxynaphthalene-1-carboxamide 24. To a 
stirred solution of compound 2722 (0.50 g, 2.94 mmol) in THF (30 mL) was added 3,4-
(methylenedioxy)aniline (0.41 g, 2.94 mmol). The mixture was stirred at reflux for 5 h and 
then evaporated. The crude product was purified by column chromatography (eluent: CH2Cl2 
changing to CH2Cl2/ MeOH 9.5:0.5) giving compound 24 (0.41 g, 45%) as a cream powder, 
m.p. 162 °C. HRMS (NSI) for C18H13NO4. Calculated mass of molecular ion 308.0917 
[M+H]+. Measured mass: 308.0919; IR νmax cm-1 3242, 3150-2400, 1612, 1557, 1214, 1038, 
812, 755; 1H-NMR (400 MHz; d6-DMSO) δH 10.22 (1H, s, broad, OH), 10.05 (1H, s, NH), 
7.90 (1H, dd, J = 8.7 and 1.2 Hz, Ar-H), 7.51-7.33 (5H, m, Ar-H), 7.11 (1H, dd, J= 8.7 and 
2.1 Hz, Ar-H), 6.86 (1H, d, J = 8.2 Hz, Ar-H), 6.84 (1H, dd, J= 7.3 and 1.4 Hz, Ar-H), 5.99 
(2H, s, CH2); 13C-NMR (101 MHz; d6-DMSO) δC 169.7 (C=O), 153.8 (Ar-C), 147.5 (Ar-C), 
143.1 (Ar-C), 135.5 (Ar-C), 135.1 (2 x Ar-C), 129.0 (Ar-C), 127.4 (Ar-C), 125.8 (Ar-C), 
124.7 (Ar-C), 121.1 (Ar-C), 119.2 (Ar-C), 112.6 (Ar-C), 110.1 (Ar-C), 108.5 (Ar-C), 102.0 
(Ar-C), 101.3 (CH2).     
7.1.7.8 4-[Methyl(4-nitrophenyl)amino]butanoic acid 38. A mixture of 1-fluoro-4-
nitrobenzene (1.00 g, 7.09 mmol), N-methyl-γ-aminobutyric acid hydrochloride (1.20 g, 7.80 
mmol) and NaHCO3 (1.49 g, 17.73 mmol) in EtOH/H2O (1:1, 100 mL) was heated at reflux 
for 16 h. The reaction mixture was allowed to cool to room temperature and the ethanol was 
evaporated. The remaining solution was acidified to pH 1-2 by the addition of 2M aqueous 
HCl solution. The mixture was extracted twice with EtOAc, the combined organic extracts 
were washed with H2O and then brine, dried (MgSO4) and evaporated giving compound 38 
(1.04 g, 62%) as a yellow solid, m.p. 139-141 oC. LRMS (ESI) for C11H15N2O4. Calculated 
mass of molecular ion [M+H]+ 239.25. Measured mass: 239.05; IR νmax cm-1 3000, 1686, 
1577, 1477, 1226; 1H-NMR (270 MHz; d6-DMSO) δH 12.17 (1H, s, broad, OH), 8.04 (2H, d, 
J = 9.14 Hz, Ar-H), 6.80 (2H, d, J = 9.7 Hz, Ar-H), 3.49 (2H, t, J = 7.4 Hz, CH2), 3.05 (3H, s, 
N-CH3), 2.29 (2H, t, J = 7.4 Hz, CH2), 1.74 (2H, quintet, J = 7.4 Hz , CH2); 13C-NMR (101 
MHz; d6-DMSO) δC  174.7 (C=O), 154.0 (Ar-C), 135.9 (Ar-C), 126.4 (2 x Ar-C), 111.1 (2 x 
Ar-C), 51.4 (CH2), 38.8 (CH3), 31.1 (CH2), 22.2 (CH2). 
7.1.7.9. 4-[Methyl(4-nitrophenyl)amino]-N-2-(phenylethyl)butanamide 39. Compound 38 
(1.00 g, 4.20 mmol) and N-methylmorpholine (0.43 g, 4.20 mmol) were dissolved in dry THF 
(20 mL) and cooled to -5°C. IBCF (0.55 g, 4.00 mmol) was then added dropwise to the 
reaction mixture. After 90 seconds, 2-phenylethylamine (0.48 g, 4.00 mmol) was added 
dropwise and the reaction was stirred at -5 °C for 1 h before being allowed to warm to room 
temperature and stirred for 16 h. The THF was evaporated and the residue dissolved in 
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CH2Cl2. The solution was then washed with 0.1 M aqueous citric acid solution, saturated 
aqueous NaHCO3 solution, water and brine. The organic layer was dried (MgSO4) and 
evaporated giving compound 39 (0.97 g, 71%) as a yellow solid, m.p. 131-133 oC. LRMS 
(ESI) for C19H24N3O3. Calculated mass of molecular ion [M+H]+ 342.41. Measured mass: 
342.04; IR νmax cm-1 3289, 1643, 1594, 1477, 1279;  1H-NMR (400 MHz; d6-DMSO) δH 8.05 
(2H, d, J = 9.2 Hz, Ar-H), 7.99 (1H, t, J = 6.0 Hz, NH), 7.30-7.17 (5H, m, Ar-H), 6.78 (2H, 
d, J = 8.7 Hz, Ar-H), 3.40 (2H, t, J = 6.9 Hz, CH2), 3.29 (2H, q, J = 6.0 Hz, CH2), 3.03 (3H, 
s, N-CH3), 2.71 (2H, t, J = 7.3 Hz, CH2), 2.11 (2H, t, J = 7.3 Hz, CH2), 1.75 (2H, quintet, J = 
7.3 Hz, CH2); 13C-NMR (101 MHz; d6-DMSO) δC  171.9 (C=O), 154.1 (Ar-C), 140.0 (Ar-C), 
135.9 (Ar-C), 129.1 (2 x Ar-C), 128.8 (2 x Ar-C), 126.6 (Ar-C), 126.4 (2 x Ar-C), 111.1 (2 x 
Ar-C), 51.7 (CH2), 40.7 (CH2), 38.9 (CH3), 35.7 (CH2), 32.5 (CH2), 22.8 (CH2). 
7.1.7.10. 4-[4-Aminophenyl)(methyl)amino]-N-2-(phenylethyl)butanamide 40. A mixture 
of compound 39 (0.31g, 1.00 mmol) and SnCl2.2H2O (0.68 g, 3.00 mmol) in ethanol (30 mL) 
was heated at reflux for 16 h. The solution was allowed to cool to rt and the pH was adjusted 
to 8-10 by the addition of 2M aqueous NaOH solution. The solution was then filtered through 
celite and the ethanol evaporated. The residue was dissolved in CH2Cl2 (30 mL) and the 
solution was filtered. The organic layer was washed with water and then brine and dried 
(MgSO4). The solvent was evaporated giving compound 40 (0.22 g, 78%) as a brown, oily 
solid. LRMS (ESI) for C19H23N3O3. Calculated mass of molecular ion M+ 312.44. Measured 
mass: 312.07; 1H-NMR (400 MHz; d6-DMSO) δH 7.80 (1H, t, J = 5.5 Hz, NH), 7.25-7.11 
(5H, m, Ar-H), 6.44 (4H, q, J = 8.7 Hz, Ar-H), 4.40 (2H, broad s, NH2), 3.55 (2H, s, CH2), 
3.27 (2H, q, J = 6.4 Hz, CH2), 2.73 (3H, s, CH3), 2.65 (2H, t, J = 7.3 Hz, CH2); 13C-NMR 
(101 MHz; d6-DMSO) δC 170.7 (C=O), 141.9 (Ar-C), 140.8 (Ar-C), 139.9 (Ar-C), 129.2 (2 x 
Ar-C), 128.8 (2 x Ar-C), 126.6 (Ar-C), 115.6 (2 x Ar-C), 115.2 (2 x Ar-C), 58.7 (CH2), 40.7 
(CH3), 40.5 (CH2), 35.6 (CH2).  
7.1.7.11. 4-[4-Aminophenyl)(methyl)amino]-N-2-(phenylethyl)butanamide; Boc L-
alanine derivative 41. Using a similar procedure to that described in Section 7.1.4, but at -15 
oC, compound 41 was prepared from Boc-L-alanine (0.19 g, 0.42 mmol), N-
methylmorpholine (0.04 g, 0.42 mmol), IBCF(0.06 g, 0.40 mmol) and compound 40 (0.13 g, 
0.40 mmol) in dry THF (20 mL). Compound 41 (0.13 g, 65%). was obtained as a yellow oil. 
HRMS (NSI) for C27H39N4O4. Calculated mass of molecular ion [M+H]+ 483.2966. 
Measured mass: 483.2962; 1H-NMR (400 MHz; CDCl3) δH 9.58 (1H, s, NH), 7.91 (1H, t, J = 
5.5 Hz, NH), 7.38 (2H, J = 9.2 Hz, Ar-H), 7.29-7.19 (6H, 5 x Ar-H NH), 6.64 (2H, d, J = 9.2 
Hz, Ar-H), 4.11-4.04 (1H, m, CH), 3.31-3.19 (4H, m, CH2), 2.81 (3H, s, CH3), 2.70 (2H, t, J 
= 6.9 Hz, CH2), 2.07 (2H, t, J = 7.8 Hz, CH2), 1.67 (2H, quintet, J = 7.3 Hz, CH2), 1.38 (9H, 
s, 3 x CH3), 1.24 (3H, d, J = 7.3 Hz, CH3); 13C-NMR (101 MHz; CDCl3) δC 172.6 (C=O), 
170.9 (C=O), 155.9 (C=O), 146.8 (Ar-C), 139.0 (Ar-C), 128.8 (2 x Ar-C), 128.7 (2 x Ar-C), 
127.3 (Ar-C), 126.6 (Ar-C), 122.1 (2 x Ar-C), 112.7 (Ar-C), 80.3 (C(CH3)3), 52.2 (CH2), 50.7 
(CH), 40.7 (CH2), 38.6 (CH3), 35.7 (CH2), 33.7 (CH2), 28.4 (3 x CH3), 22.8 (CH2), 18.3 
(CH3).  
7.1.7.12. 4-[4-Aminophenyl)(methyl)amino]-N-2-(phenylethyl)butanamide; L-alanine 
derivative TFA salt 42. A solution of compound 41 (0.09 g, 0.19 mmol) in a mixture 
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CH2Cl2/TFA (2:1, 15 mL) was stirred at room temperature for 2 h. The solvent was 
evaporated giving compound 42 (0.05 g, 48%) as a brown, oily solid. HRMS (NSI) for 
C22H32N4O2. Calculated mass of molecular ion [M+H]+ 383.2442. Measured mass: 383.2441; 
1H-NMR (400 MHz; d6-DMSO) δH 10.37 (1H, s, NH), 8.24 (3H, s, NH3+), 7.98 (1H, t, J = 
5.5 Hz, NH), 7.52 (2H, d, J = 8.7 Hz, Ar-H), 7.29-7.19 (5H, m, Ar-H), 6.99 (2H, broad s, Ar-
H), 4.00-3.98 (1H, m, CH), 3.33-3.24 (4H, m, 2 x CH2), 2.94 (3H, s, CH3), 2.70 (2H, t, J = 
7.3 Hz, CH2), 2.09 (2H, t, J = 7.3 Hz, CH2), 1.64 (2H, m, CH2), 1.45 (3H, d, J = 7.3 Hz, 
CH3);  13C-NMR (101 MHz; CDCl3) δC 171.7 (C=O), 168.6 (C=O), 140.0 (Ar-C), 129.1 (2 x 
Ar-C), 128.8 (2 x Ar-C), 126.6 (2 x Ar-C), 121.3 (2 x Ar-C), 117.4 (Ar-C), 114.5 (Ar-C), 
111.1 (Ar-C), 51.7 (CH2), 49.5 (CH), 40.6 (CH2), 38.8 (CH3), 35.6 (CH2), 32.5 (CH2), 21.8 
(CH2), 17.7 (CH3). 
7.1.7.13. 4-[4-Aminophenyl)(methyl)amino]-N-2-(phenylethyl)butanamide; L-
pyroglutamic acid derivative 43. Using a similar procedure to that described in Section 
7.1.6, but at -15 oC, compound 43 was prepared from L-pyroglutamic acid (0.72 g, 5.56 
mmol), N-methylmorpholine (0.56 g, 5.56 mmol), IBCF(0.72 g, 5.30 mmol) and compound 
40 (1.65 g, 5.30 mmol) in a mixture of dry THF/DMF (10:1, 10 mL). The crude dark 
coloured oil was purified by column chromatography on silica gel (eluent: CH2Cl2/EtOAc 1:1 
changing to EtOAc/MeOH 99:1) giving compound 43 (0.40 g, 18%) as a dark coloured solid, 
m.p. 100-103 °C. LRMS (ESI) for C24H30N4O3. Calculated mass of molecular ion [M+H]+ 
423.53. Measured mass: 423.10; IR νmax cm-1 3287, 1658, 1519; 1H-NMR (400 MHz; d6-
DMSO) δH 9.72 (1H, s, NH), 7.95-7.87 (2H, m, 2 x NH), 7.41 (2H, d, J = 8.7 Hz, Ar-H), 
7.29-7.17 (5H, m, Ar-H), 6.65 (2H, d, J = 9.2 Hz, Ar-H), 4.14-4.11 (1H, m, CH), 3.31-3.19 
(4H, m, 2 x CH2), 2.82 (3H, s, CH3), 2.73-2.68 (2H, m, CH2), 2.32-1.91 (6H, m, 3 x CH2), 
1.68-1.65 (2H, m, CH2); 13C-NMR (101 MHz; CDCl3) δC 178.0 (C=O), 172.2 (C=O), 170.8 
(C=O), 146.2 (Ar-C), 140.0 (Ar-C), 129.1 (2 x Ar-C), 128.8 (2 x Ar-C), 128.5 (Ar-C), 126.6 
(2 x Ar-C), 121.4 (2 x Ar-C), 112.6 (Ar-C), 56.8 (CH), 52.1 (CH2), 40.6 (CH2), 38.5 (CH3), 
35.7 (CH2), 33.1 (CH2), 29.8 (CH2), 25.9 (CH2), 22.5 (CH2).  
7.2. Microbiological work 
7.2.1. Agar plate preparation 
Each substrate (30 mg) was dissolved in a minimal volume of 1-methyl-2-pyrrolidone (200-
400 µL) and added to molten Columbia agar (99 mL) (Oxoid, Basingstoke) at 50 ºC to a final 
concentration of 300 mg L-1. 1-Naphthol (5 mg) was dissolved in deionised water (1 mL) and 
four drops of 10 M aqueous sodium hydroxide were added to aid dissolution before addition. 
Agar plates were then prepared and dried to remove excess moisture. Bacterial strains and 
yeasts obtained from various national culture collections (see Tables) were sub-cultured onto 
Columbia agar. Colonies of each strain were sampled using a loop and suspended in 0.85 % 
sterile physiological saline to generate a suspension equivalent to 108 colony forming units 
(cfu) per mL using a densitometer. Each agar plate was then inoculated with 1 µL of this 
suspension using a multipoint inoculator that delivered suspensions of 20 strains per plate. 
Plates were incubated at 37 °C in air for 24 h. Columbia agar without substrate (but with 1-
naphthol included) were prepared and inoculated concomitantly.   
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 7.2.2. Cell free extract 
A cell free extract was prepared as described previously.23 
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